<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:g="http://xbrl.dcca.dk/sob" xmlns:b="http://xbrl.dcca.dk/entryBalanceSheetAccountFormIncomeStatementByNature" xmlns:h="http://xbrl.dcca.dk/mrv" xmlns:f="http://xbrl.dcca.dk/arr" xmlns:d="http://xbrl.dcca.dk/cmn" xmlns:e="http://xbrl.dcca.dk/fsa" xmlns:c="http://xbrl.dcca.dk/gsd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://xbrl.dcca.dk/entryBalanceSheetAccountFormIncomeStatementByNature http://archprod.service.eogs.dk/taxonomy/20211001/entryDanishGAAPBalanceSheetAccountFormIncomeStatementByNatureIncludingManagementsReviewStatisticsAndTax20211001.xsd"><link:schemaRef xlink:type="simple" xlink:href="http://archprod.service.eogs.dk/taxonomy/20211001/entryDanishGAAPBalanceSheetAccountFormIncomeStatementByNatureIncludingManagementsReviewStatisticsAndTax20211001.xsd"/><c:InformationOnTypeOfSubmittedReport contextRef="c1">Årsrapport</c:InformationOnTypeOfSubmittedReport><c:IdentificationNumberCvrOfSubmittingEnterprise contextRef="c1">15915641</c:IdentificationNumberCvrOfSubmittingEnterprise><c:NameOfSubmittingEnterprise contextRef="c1">Christensen Kjærulff, Statsautoriseret Revisionsaktieselskab</c:NameOfSubmittingEnterprise><c:AddressOfSubmittingEnterpriseStreetAndNumber contextRef="c1">Store Kongensgade, 68</c:AddressOfSubmittingEnterpriseStreetAndNumber><c:AddressOfSubmittingEnterprisePostcodeAndTown contextRef="c1">1264, København K</c:AddressOfSubmittingEnterprisePostcodeAndTown><c:PrecedingReportingPeriodStartDate contextRef="c1">2020-10-01</c:PrecedingReportingPeriodStartDate><c:PredingReportingPeriodEndDate contextRef="c1">2021-09-30</c:PredingReportingPeriodEndDate><c:ReportingPeriodStartDate contextRef="c1">2021-10-01</c:ReportingPeriodStartDate><c:ReportingPeriodEndDate contextRef="c1">2022-09-30</c:ReportingPeriodEndDate><c:IdentificationNumberCvrOfReportingEntity contextRef="c1">35671099</c:IdentificationNumberCvrOfReportingEntity><c:NameOfReportingEntity contextRef="c1">Celvivo ApS</c:NameOfReportingEntity><c:AddressOfReportingEntityStreetName contextRef="c1">Ørbækvej</c:AddressOfReportingEntityStreetName><c:AddressOfReportingEntityStreetBuildingIdentifier contextRef="c1">264</c:AddressOfReportingEntityStreetBuildingIdentifier><c:AddressOfReportingEntityPostCodeIdentifier contextRef="c1">5220</c:AddressOfReportingEntityPostCodeIdentifier><c:AddressOfReportingEntityDistrictName contextRef="c1">Odense SØ</c:AddressOfReportingEntityDistrictName><c:DateOfFoundationOfReportingEntity contextRef="c1">2014-02-26</c:DateOfFoundationOfReportingEntity><c:RegisteredOfficeOfReportingEntity contextRef="c1">Odense</c:RegisteredOfficeOfReportingEntity><d:NameOfAuditFirm contextRef="c37">Christensen Kjærulff, Statsautoriseret Revisionsaktieselskab</d:NameOfAuditFirm><d:IdentificationNumberCvrOfAuditFirm contextRef="c37">15915641</d:IdentificationNumberCvrOfAuditFirm><d:NameAndSurnameOfAuditor contextRef="c37">Elan Schapiro</d:NameAndSurnameOfAuditor><d:DescriptionOfAuditor contextRef="c37">statsautoriseret revisor</d:DescriptionOfAuditor><d:IdentificationNumberOfAuditor contextRef="c37">mne33765</d:IdentificationNumberOfAuditor><c:AddressOfAuditorStreetName contextRef="c37">Store Kongensgade</c:AddressOfAuditorStreetName><c:AddressOfAuditorStreetBuildingIdentifier contextRef="c37">68</c:AddressOfAuditorStreetBuildingIdentifier><c:AddressOfAuditorPostCodeIdentifier contextRef="c37">1264</c:AddressOfAuditorPostCodeIdentifier><c:AddressOfAuditorDistrictName contextRef="c37">København K</c:AddressOfAuditorDistrictName><c:AddressOfAuditorCountry contextRef="c37">Danmark</c:AddressOfAuditorCountry><c:TelephoneNumberOfAuditor contextRef="c37">+45 33 30 15 15</c:TelephoneNumberOfAuditor><c:EmailOfAuditor contextRef="c1">ck@ck.dk</c:EmailOfAuditor><c:DateOfGeneralMeeting contextRef="c1">2023-01-16</c:DateOfGeneralMeeting><c:NameAndSurnameOfChairmanOfGeneralMeeting contextRef="c1">Lars Nørgaard</c:NameAndSurnameOfChairmanOfGeneralMeeting><e:ClassOfReportingEntity contextRef="c1">Regnskabsklasse B</e:ClassOfReportingEntity><d:TypeOfAuditorAssistance contextRef="c1">Revisionspåtegning</d:TypeOfAuditorAssistance><c:ToolForPreparingTheXBRLInstanceDocument contextRef="c1">CaseWare fra Revisorgruppen Danmark</c:ToolForPreparingTheXBRLInstanceDocument><f:AddresseeOfAuditorsReportOnAuditedFinancialStatements contextRef="c1">kapitalejerne</f:AddresseeOfAuditorsReportOnAuditedFinancialStatements><f:SignatureOfAuditorsPlace contextRef="c1">København</f:SignatureOfAuditorsPlace><f:SignatureOfAuditorsDate contextRef="c1">2023-01-06</f:SignatureOfAuditorsDate><g:PlaceOfSignatureOfStatement contextRef="c1">Odense SØ</g:PlaceOfSignatureOfStatement><g:DateOfApprovalOfAnnualReport contextRef="c1">2023-01-06</g:DateOfApprovalOfAnnualReport><f:TypeOfBasisForModifiedOpinionOnAuditedFinancialStatements contextRef="c1">Grundlag for konklusion</f:TypeOfBasisForModifiedOpinionOnAuditedFinancialStatements><f:TypeOfModifiedOpinionOnAuditedFinancialStatements contextRef="c1">Konklusion</f:TypeOfModifiedOpinionOnAuditedFinancialStatements><e:GrossProfitLoss contextRef="c1" unitRef="u5" decimals="0">-2493498</e:GrossProfitLoss><e:GrossProfitLoss contextRef="c2" unitRef="u5" decimals="0">2656320</e:GrossProfitLoss><e:EmployeeBenefitsExpense contextRef="c1" unitRef="u5" decimals="0">11279000</e:EmployeeBenefitsExpense><e:EmployeeBenefitsExpense contextRef="c2" unitRef="u5" decimals="0">7974283</e:EmployeeBenefitsExpense><e:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss contextRef="c1" unitRef="u5" decimals="0">5269260</e:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss><e:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss contextRef="c2" unitRef="u5" decimals="0">625731</e:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss><e:ProfitLossFromOrdinaryOperatingActivities contextRef="c1" unitRef="u5" decimals="0">-19041758</e:ProfitLossFromOrdinaryOperatingActivities><e:ProfitLossFromOrdinaryOperatingActivities contextRef="c2" unitRef="u5" decimals="0">-5943694</e:ProfitLossFromOrdinaryOperatingActivities><e:IncomeFromInvestmentsInGroupEnterprises contextRef="c1" unitRef="u5" decimals="0">-298930</e:IncomeFromInvestmentsInGroupEnterprises><e:IncomeFromInvestmentsInGroupEnterprises contextRef="c2" unitRef="u5" decimals="0">0</e:IncomeFromInvestmentsInGroupEnterprises><e:OtherFinanceIncome contextRef="c1" unitRef="u5" decimals="0">20400</e:OtherFinanceIncome><e:OtherFinanceIncome contextRef="c2" unitRef="u5" decimals="0">7690</e:OtherFinanceIncome><e:OtherFinanceExpenses contextRef="c1" unitRef="u5" decimals="0">2606277</e:OtherFinanceExpenses><e:OtherFinanceExpenses contextRef="c2" unitRef="u5" decimals="0">1259788</e:OtherFinanceExpenses><e:ProfitLossFromOrdinaryActivitiesBeforeTax contextRef="c1" unitRef="u5" decimals="0">-21926565</e:ProfitLossFromOrdinaryActivitiesBeforeTax><e:ProfitLossFromOrdinaryActivitiesBeforeTax contextRef="c2" unitRef="u5" decimals="0">-7195792</e:ProfitLossFromOrdinaryActivitiesBeforeTax><e:TaxExpenseOnOrdinaryActivities contextRef="c1" unitRef="u5" decimals="0">-5849067</e:TaxExpenseOnOrdinaryActivities><e:TaxExpenseOnOrdinaryActivities contextRef="c2" unitRef="u5" decimals="0">-2468887</e:TaxExpenseOnOrdinaryActivities><e:ProfitLoss contextRef="c1" unitRef="u5" decimals="0">-16077498</e:ProfitLoss><e:ProfitLoss contextRef="c2" unitRef="u5" decimals="0">-4726905</e:ProfitLoss><e:ProfitLoss contextRef="c63" unitRef="u5" decimals="0">-16077498</e:ProfitLoss><e:ProfitLoss contextRef="c64" unitRef="u5" decimals="0">-4726905</e:ProfitLoss><e:CompletedDevelopmentProjects contextRef="c4" unitRef="u5" decimals="0">22203768</e:CompletedDevelopmentProjects><e:CompletedDevelopmentProjects contextRef="c3" unitRef="u5" decimals="0">0</e:CompletedDevelopmentProjects><e:AcquiredIntangibleAssets contextRef="c4" unitRef="u5" decimals="0">1619567</e:AcquiredIntangibleAssets><e:AcquiredIntangibleAssets contextRef="c3" unitRef="u5" decimals="0">1212710</e:AcquiredIntangibleAssets><e:DevelopmentProjectsInProgressAndPrepaymentsForIntangibleAssets contextRef="c4" unitRef="u5" decimals="0">0</e:DevelopmentProjectsInProgressAndPrepaymentsForIntangibleAssets><e:DevelopmentProjectsInProgressAndPrepaymentsForIntangibleAssets contextRef="c3" unitRef="u5" decimals="0">19072339</e:DevelopmentProjectsInProgressAndPrepaymentsForIntangibleAssets><e:IntangibleAssets contextRef="c4" unitRef="u5" decimals="0">23823335</e:IntangibleAssets><e:IntangibleAssets contextRef="c3" unitRef="u5" decimals="0">20285049</e:IntangibleAssets><e:FixturesFittingsToolsAndEquipment contextRef="c4" unitRef="u5" decimals="0">2545803</e:FixturesFittingsToolsAndEquipment><e:FixturesFittingsToolsAndEquipment contextRef="c3" unitRef="u5" decimals="0">2538617</e:FixturesFittingsToolsAndEquipment><e:LeaseholdImprovements contextRef="c4" unitRef="u5" decimals="0">944970</e:LeaseholdImprovements><e:LeaseholdImprovements contextRef="c3" unitRef="u5" decimals="0">666201</e:LeaseholdImprovements><e:PropertyPlantAndEquipment contextRef="c4" unitRef="u5" decimals="0">3490773</e:PropertyPlantAndEquipment><e:PropertyPlantAndEquipment contextRef="c3" unitRef="u5" decimals="0">3204818</e:PropertyPlantAndEquipment><e:LongtermInvestmentsInGroupEnterprises contextRef="c4" unitRef="u5" decimals="0">0</e:LongtermInvestmentsInGroupEnterprises><e:LongtermInvestmentsInGroupEnterprises contextRef="c3" unitRef="u5" decimals="0">6671</e:LongtermInvestmentsInGroupEnterprises><e:DepositsLongtermInvestmentsAndReceivables contextRef="c4" unitRef="u5" decimals="0">138970</e:DepositsLongtermInvestmentsAndReceivables><e:DepositsLongtermInvestmentsAndReceivables contextRef="c3" unitRef="u5" decimals="0">134605</e:DepositsLongtermInvestmentsAndReceivables><e:LongtermInvestmentsAndReceivables contextRef="c4" unitRef="u5" decimals="0">138970</e:LongtermInvestmentsAndReceivables><e:LongtermInvestmentsAndReceivables contextRef="c3" unitRef="u5" decimals="0">141276</e:LongtermInvestmentsAndReceivables><e:NoncurrentAssets contextRef="c4" unitRef="u5" decimals="0">27453078</e:NoncurrentAssets><e:NoncurrentAssets contextRef="c3" unitRef="u5" decimals="0">23631143</e:NoncurrentAssets><e:RawMaterialsAndConsumables contextRef="c4" unitRef="u5" decimals="0">1361433</e:RawMaterialsAndConsumables><e:RawMaterialsAndConsumables contextRef="c3" unitRef="u5" decimals="0">68613</e:RawMaterialsAndConsumables><e:WorkInProgress contextRef="c4" unitRef="u5" decimals="0">145870</e:WorkInProgress><e:WorkInProgress contextRef="c3" unitRef="u5" decimals="0">120162</e:WorkInProgress><e:ManufacturedGoodsAndGoodsForResale contextRef="c4" unitRef="u5" decimals="0">1103831</e:ManufacturedGoodsAndGoodsForResale><e:ManufacturedGoodsAndGoodsForResale contextRef="c3" unitRef="u5" decimals="0">667150</e:ManufacturedGoodsAndGoodsForResale><e:Inventories contextRef="c4" unitRef="u5" decimals="0">2611134</e:Inventories><e:Inventories contextRef="c3" unitRef="u5" decimals="0">855925</e:Inventories><e:ShorttermTradeReceivables contextRef="c4" unitRef="u5" decimals="0">350570</e:ShorttermTradeReceivables><e:ShorttermTradeReceivables contextRef="c3" unitRef="u5" decimals="0">189886</e:ShorttermTradeReceivables><e:ShorttermReceivablesFromGroupEnterprises contextRef="c4" unitRef="u5" decimals="0">1259956</e:ShorttermReceivablesFromGroupEnterprises><e:ShorttermReceivablesFromGroupEnterprises contextRef="c3" unitRef="u5" decimals="0">0</e:ShorttermReceivablesFromGroupEnterprises><e:CurrentDeferredTaxAssets contextRef="c4" unitRef="u5" decimals="0">2450297</e:CurrentDeferredTaxAssets><e:CurrentDeferredTaxAssets contextRef="c3" unitRef="u5" decimals="0">0</e:CurrentDeferredTaxAssets><e:ShorttermTaxReceivables contextRef="c4" unitRef="u5" decimals="0">4044643</e:ShorttermTaxReceivables><e:ShorttermTaxReceivables contextRef="c3" unitRef="u5" decimals="0">4822843</e:ShorttermTaxReceivables><e:OtherShorttermReceivables contextRef="c4" unitRef="u5" decimals="0">298515</e:OtherShorttermReceivables><e:OtherShorttermReceivables contextRef="c3" unitRef="u5" decimals="0">1360364</e:OtherShorttermReceivables><e:DeferredIncomeAssets contextRef="c4" unitRef="u5" decimals="0">127316</e:DeferredIncomeAssets><e:DeferredIncomeAssets contextRef="c3" unitRef="u5" decimals="0">165501</e:DeferredIncomeAssets><e:ShorttermReceivables contextRef="c4" unitRef="u5" decimals="0">8531297</e:ShorttermReceivables><e:ShorttermReceivables contextRef="c3" unitRef="u5" decimals="0">6538594</e:ShorttermReceivables><e:CashAndCashEquivalents contextRef="c4" unitRef="u5" decimals="0">21876</e:CashAndCashEquivalents><e:CashAndCashEquivalents contextRef="c3" unitRef="u5" decimals="0">178191</e:CashAndCashEquivalents><e:CurrentAssets contextRef="c4" unitRef="u5" decimals="0">11164307</e:CurrentAssets><e:CurrentAssets contextRef="c3" unitRef="u5" decimals="0">7572710</e:CurrentAssets><e:Assets contextRef="c4" unitRef="u5" decimals="0">38617385</e:Assets><e:Assets contextRef="c3" unitRef="u5" decimals="0">31203853</e:Assets><e:RecognisedButNotOwnedAssets contextRef="c1" unitRef="u5" decimals="0">0</e:RecognisedButNotOwnedAssets><e:ContributedCapital contextRef="c4" unitRef="u5" decimals="0">53846</e:ContributedCapital><e:ContributedCapital contextRef="c3" unitRef="u5" decimals="0">53846</e:ContributedCapital><e:SharePremium contextRef="c4" unitRef="u5" decimals="0">0</e:SharePremium><e:SharePremium contextRef="c3" unitRef="u5" decimals="0">380754</e:SharePremium><e:ReserveForDevelopmentExpenditure contextRef="c4" unitRef="u5" decimals="0">17318939</e:ReserveForDevelopmentExpenditure><e:ReserveForDevelopmentExpenditure contextRef="c3" unitRef="u5" decimals="0">14876424</e:ReserveForDevelopmentExpenditure><e:ReserveForCurrentValueAdjustmentsOfCurrencyGains contextRef="c4" unitRef="u5" decimals="0">9428</e:ReserveForCurrentValueAdjustmentsOfCurrencyGains><e:ReserveForCurrentValueAdjustmentsOfCurrencyGains contextRef="c3" unitRef="u5" decimals="0">0</e:ReserveForCurrentValueAdjustmentsOfCurrencyGains><e:RetainedEarnings contextRef="c4" unitRef="u5" decimals="0">-38925321</e:RetainedEarnings><e:RetainedEarnings contextRef="c3" unitRef="u5" decimals="0">-20786062</e:RetainedEarnings><e:Equity contextRef="c4" unitRef="u5" decimals="0">-21543108</e:Equity><e:Equity contextRef="c3" unitRef="u5" decimals="0">-5475038</e:Equity><e:ProvisionsForDeferredTax contextRef="c4" unitRef="u5" decimals="0">0</e:ProvisionsForDeferredTax><e:ProvisionsForDeferredTax contextRef="c3" unitRef="u5" decimals="0">1312171</e:ProvisionsForDeferredTax><e:Provisions contextRef="c4" unitRef="u5" decimals="0">0</e:Provisions><e:Provisions contextRef="c3" unitRef="u5" decimals="0">1312171</e:Provisions><e:OtherLongtermPayables contextRef="c4" unitRef="u5" decimals="0">322232</e:OtherLongtermPayables><e:OtherLongtermPayables contextRef="c3" unitRef="u5" decimals="0">322232</e:OtherLongtermPayables><e:LongtermDeferredIncome contextRef="c4" unitRef="u5" decimals="0">1300025</e:LongtermDeferredIncome><e:LongtermDeferredIncome contextRef="c3" unitRef="u5" decimals="0">0</e:LongtermDeferredIncome><e:LongtermLiabilitiesOtherThanProvisions contextRef="c4" unitRef="u5" decimals="0">1622257</e:LongtermLiabilitiesOtherThanProvisions><e:LongtermLiabilitiesOtherThanProvisions contextRef="c3" unitRef="u5" decimals="0">322232</e:LongtermLiabilitiesOtherThanProvisions><e:ShorttermDebtToBanks contextRef="c4" unitRef="u5" decimals="0">8277811</e:ShorttermDebtToBanks><e:ShorttermDebtToBanks contextRef="c3" unitRef="u5" decimals="0">0</e:ShorttermDebtToBanks><e:ShorttermTradePayables contextRef="c4" unitRef="u5" decimals="0">1119189</e:ShorttermTradePayables><e:ShorttermTradePayables contextRef="c3" unitRef="u5" decimals="0">1233764</e:ShorttermTradePayables><e:ShorttermPayablesToGroupEnterprises contextRef="c4" unitRef="u5" decimals="0">22135932</e:ShorttermPayablesToGroupEnterprises><e:ShorttermPayablesToGroupEnterprises contextRef="c3" unitRef="u5" decimals="0">21084591</e:ShorttermPayablesToGroupEnterprises><e:OtherShorttermPayables contextRef="c4" unitRef="u5" decimals="0">26224685</e:OtherShorttermPayables><e:OtherShorttermPayables contextRef="c3" unitRef="u5" decimals="0">12726133</e:OtherShorttermPayables><e:ShorttermDeferredIncome contextRef="c4" unitRef="u5" decimals="0">780619</e:ShorttermDeferredIncome><e:ShorttermDeferredIncome contextRef="c3" unitRef="u5" decimals="0">0</e:ShorttermDeferredIncome><e:ShorttermLiabilitiesOtherThanProvisions contextRef="c4" unitRef="u5" decimals="0">58538236</e:ShorttermLiabilitiesOtherThanProvisions><e:ShorttermLiabilitiesOtherThanProvisions contextRef="c3" unitRef="u5" decimals="0">35044488</e:ShorttermLiabilitiesOtherThanProvisions><e:LiabilitiesOtherThanProvisions contextRef="c4" unitRef="u5" decimals="0">60160493</e:LiabilitiesOtherThanProvisions><e:LiabilitiesOtherThanProvisions contextRef="c3" unitRef="u5" decimals="0">35366720</e:LiabilitiesOtherThanProvisions><e:LiabilitiesAndEquity contextRef="c4" unitRef="u5" decimals="0">38617385</e:LiabilitiesAndEquity><e:LiabilitiesAndEquity contextRef="c3" unitRef="u5" decimals="0">31203853</e:LiabilitiesAndEquity><e:WagesAndSalaries contextRef="c1" unitRef="u5" decimals="0">10599814</e:WagesAndSalaries><e:WagesAndSalaries contextRef="c2" unitRef="u5" decimals="0">7374312</e:WagesAndSalaries><e:PostemploymentBenefitExpense contextRef="c1" unitRef="u5" decimals="0">562757</e:PostemploymentBenefitExpense><e:PostemploymentBenefitExpense contextRef="c2" unitRef="u5" decimals="0">523682</e:PostemploymentBenefitExpense><e:SocialSecurityContributions contextRef="c1" unitRef="u5" decimals="0">116429</e:SocialSecurityContributions><e:SocialSecurityContributions contextRef="c2" unitRef="u5" decimals="0">76289</e:SocialSecurityContributions><e:EmployeeBenefitsExpense contextRef="c1" unitRef="u5" decimals="0">11279000</e:EmployeeBenefitsExpense><e:EmployeeBenefitsExpense contextRef="c2" unitRef="u5" decimals="0">7974283</e:EmployeeBenefitsExpense><e:AverageNumberOfEmployees contextRef="c1" unitRef="u7" decimals="INF">13</e:AverageNumberOfEmployees><e:AverageNumberOfEmployees contextRef="c2" unitRef="u7" decimals="INF">9</e:AverageNumberOfEmployees><e:InterestExpenseAssignedToGroupEnterprises contextRef="c1" unitRef="u5" decimals="0">1051341</e:InterestExpenseAssignedToGroupEnterprises><e:InterestExpenseAssignedToGroupEnterprises contextRef="c2" unitRef="u5" decimals="0">882552</e:InterestExpenseAssignedToGroupEnterprises><e:OtherInterestExpenses contextRef="c1" unitRef="u5" decimals="0">1554936</e:OtherInterestExpenses><e:OtherInterestExpenses contextRef="c2" unitRef="u5" decimals="0">377236</e:OtherInterestExpenses><e:OtherFinanceExpenses contextRef="c1" unitRef="u5" decimals="0">2606277</e:OtherFinanceExpenses><e:OtherFinanceExpenses contextRef="c2" unitRef="u5" decimals="0">1259788</e:OtherFinanceExpenses><e:AdditionsToIntangibleAssets contextRef="c52" unitRef="u5" decimals="0">5996979</e:AdditionsToIntangibleAssets><e:IncreaseDecreaseOfIntangibleAssetsThroughTransfers contextRef="c52" unitRef="u5" decimals="0">20258486</e:IncreaseDecreaseOfIntangibleAssetsThroughTransfers><e:IntangibleAssetsGross contextRef="c53" unitRef="u5" decimals="0">26255465</e:IntangibleAssetsGross><e:AmortisationOfIntangibleAssets contextRef="c52" unitRef="u5" decimals="0">4051697</e:AmortisationOfIntangibleAssets><e:AccumulatedImpairmentLossesAndAmortisationOfIntangibleAssets contextRef="c53" unitRef="u5" decimals="0">4051697</e:AccumulatedImpairmentLossesAndAmortisationOfIntangibleAssets><e:IntangibleAssets contextRef="c53" unitRef="u5" decimals="0">22203768</e:IntangibleAssets><e:IntangibleAssetsGross contextRef="c231" unitRef="u5" decimals="0">1212710</e:IntangibleAssetsGross><e:AdditionsToIntangibleAssets contextRef="c232" unitRef="u5" decimals="0">649399</e:AdditionsToIntangibleAssets><e:IntangibleAssetsGross contextRef="c233" unitRef="u5" decimals="0">1862109</e:IntangibleAssetsGross><e:AmortisationOfIntangibleAssets contextRef="c232" unitRef="u5" decimals="0">242542</e:AmortisationOfIntangibleAssets><e:AccumulatedImpairmentLossesAndAmortisationOfIntangibleAssets contextRef="c233" unitRef="u5" decimals="0">242542</e:AccumulatedImpairmentLossesAndAmortisationOfIntangibleAssets><e:IntangibleAssets contextRef="c233" unitRef="u5" decimals="0">1619567</e:IntangibleAssets><e:IntangibleAssetsGross contextRef="c42" unitRef="u5" decimals="0">19072339</e:IntangibleAssetsGross><e:AdditionsToIntangibleAssets contextRef="c46" unitRef="u5" decimals="0">1186117</e:AdditionsToIntangibleAssets><e:IncreaseDecreaseOfIntangibleAssetsThroughTransfers contextRef="c46" unitRef="u5" decimals="0">-20258456</e:IncreaseDecreaseOfIntangibleAssetsThroughTransfers><e:PropertyPlantAndEquipmentGross contextRef="c99" unitRef="u5" decimals="0">3469932</e:PropertyPlantAndEquipmentGross><e:AdditionsToPropertyPlantAndEquipment contextRef="c100" unitRef="u5" decimals="0">798565</e:AdditionsToPropertyPlantAndEquipment><e:PropertyPlantAndEquipmentGross contextRef="c101" unitRef="u5" decimals="0">4268497</e:PropertyPlantAndEquipmentGross><e:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment contextRef="c99" unitRef="u5" decimals="0">931315</e:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment><e:DepreciationOfPropertyPlantAndEquipment contextRef="c100" unitRef="u5" decimals="0">791379</e:DepreciationOfPropertyPlantAndEquipment><e:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment contextRef="c101" unitRef="u5" decimals="0">1722694</e:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment><e:PropertyPlantAndEquipment contextRef="c101" unitRef="u5" decimals="0">2545803</e:PropertyPlantAndEquipment><e:PropertyPlantAndEquipmentGross contextRef="c105" unitRef="u5" decimals="0">696321</e:PropertyPlantAndEquipmentGross><e:AdditionsToPropertyPlantAndEquipment contextRef="c106" unitRef="u5" decimals="0">462411</e:AdditionsToPropertyPlantAndEquipment><e:PropertyPlantAndEquipmentGross contextRef="c107" unitRef="u5" decimals="0">1158732</e:PropertyPlantAndEquipmentGross><e:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment contextRef="c105" unitRef="u5" decimals="0">30120</e:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment><e:DepreciationOfPropertyPlantAndEquipment contextRef="c106" unitRef="u5" decimals="0">183642</e:DepreciationOfPropertyPlantAndEquipment><e:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment contextRef="c107" unitRef="u5" decimals="0">213762</e:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment><e:PropertyPlantAndEquipment contextRef="c107" unitRef="u5" decimals="0">944970</e:PropertyPlantAndEquipment><e:InvestmentsGross contextRef="c113" unitRef="u5" decimals="0">6671</e:InvestmentsGross><e:InvestmentsGross contextRef="c114" unitRef="u5" decimals="0">0</e:InvestmentsGross><e:IncreaseDecreaseOfInvestmentsThroughNetExchangeDifferences contextRef="c115" unitRef="u5" decimals="0">958</e:IncreaseDecreaseOfInvestmentsThroughNetExchangeDifferences><e:IncreaseDecreaseOfInvestmentsThroughNetExchangeDifferences contextRef="c116" unitRef="u5" decimals="0">0</e:IncreaseDecreaseOfInvestmentsThroughNetExchangeDifferences><e:AdditionsToInvestments contextRef="c115" unitRef="u5" decimals="0">0</e:AdditionsToInvestments><e:AdditionsToInvestments contextRef="c116" unitRef="u5" decimals="0">6671</e:AdditionsToInvestments><e:InvestmentsGross contextRef="c117" unitRef="u5" decimals="0">7629</e:InvestmentsGross><e:InvestmentsGross contextRef="c118" unitRef="u5" decimals="0">6671</e:InvestmentsGross><e:IncreaseDecreaseOfRevaluationsAndDevaluationsOfInvestmentsThroughNetExchangeDifferences contextRef="c115" unitRef="u5" decimals="0">8470</e:IncreaseDecreaseOfRevaluationsAndDevaluationsOfInvestmentsThroughNetExchangeDifferences><e:IncreaseDecreaseOfRevaluationsAndDevaluationsOfInvestmentsThroughNetExchangeDifferences contextRef="c116" unitRef="u5" decimals="0">0</e:IncreaseDecreaseOfRevaluationsAndDevaluationsOfInvestmentsThroughNetExchangeDifferences><e:ProfitLossRelatedToInvestments contextRef="c115" unitRef="u5" decimals="0">98628</e:ProfitLossRelatedToInvestments><e:ProfitLossRelatedToInvestments contextRef="c116" unitRef="u5" decimals="0">0</e:ProfitLossRelatedToInvestments><e:OtherAdjustmentsRelatedToInvestments contextRef="c115" unitRef="u5" decimals="0">-114727</e:OtherAdjustmentsRelatedToInvestments><e:OtherAdjustmentsRelatedToInvestments contextRef="c116" unitRef="u5" decimals="0">0</e:OtherAdjustmentsRelatedToInvestments><e:AccumulatedRevaluationsOfInvestments contextRef="c117" unitRef="u5" decimals="0">-7629</e:AccumulatedRevaluationsOfInvestments><e:AccumulatedRevaluationsOfInvestments contextRef="c118" unitRef="u5" decimals="0">0</e:AccumulatedRevaluationsOfInvestments><e:LongtermInvestmentsAndReceivables contextRef="c117" unitRef="u5" decimals="0">0</e:LongtermInvestmentsAndReceivables><e:LongtermInvestmentsAndReceivables contextRef="c118" unitRef="u5" decimals="0">6671</e:LongtermInvestmentsAndReceivables><e:InvestmentsGross contextRef="c1013" unitRef="u5" decimals="0">134605</e:InvestmentsGross><e:AdditionsToInvestments contextRef="c1014" unitRef="u5" decimals="0">4365</e:AdditionsToInvestments><e:InvestmentsGross contextRef="c1015" unitRef="u5" decimals="0">138970</e:InvestmentsGross><e:LongtermInvestmentsAndReceivables contextRef="c1015" unitRef="u5" decimals="0">138970</e:LongtermInvestmentsAndReceivables><e:Equity contextRef="c119" unitRef="u5" decimals="0">53846</e:Equity><e:Equity contextRef="c478" unitRef="u5" decimals="0">50000</e:Equity><e:IncreaseOfCapital contextRef="c120" unitRef="u5" decimals="0">0</e:IncreaseOfCapital><e:IncreaseOfCapital contextRef="c479" unitRef="u5" decimals="0">3846</e:IncreaseOfCapital><e:Equity contextRef="c121" unitRef="u5" decimals="0">53846</e:Equity><e:Equity contextRef="c480" unitRef="u5" decimals="0">53846</e:Equity><e:Equity contextRef="c122" unitRef="u5" decimals="0">380754</e:Equity><e:Equity contextRef="c484" unitRef="u5" decimals="0">0</e:Equity><e:IncreaseOfCapital contextRef="c123" unitRef="u5" decimals="0">0</e:IncreaseOfCapital><e:IncreaseOfCapital contextRef="c485" unitRef="u5" decimals="0">380754</e:IncreaseOfCapital><e:TransferredFromSharePremium contextRef="c123" unitRef="u5" decimals="0">380754</e:TransferredFromSharePremium><e:TransferredFromSharePremium contextRef="c485" unitRef="u5" decimals="0">0</e:TransferredFromSharePremium><e:Equity contextRef="c124" unitRef="u5" decimals="0">0</e:Equity><e:Equity contextRef="c486" unitRef="u5" decimals="0">380754</e:Equity><e:Equity contextRef="c1518" unitRef="u5" decimals="0">14876424</e:Equity><e:Equity contextRef="c1521" unitRef="u5" decimals="0">7168730</e:Equity><e:ProfitLoss contextRef="c1519" unitRef="u5" decimals="0">2442515</e:ProfitLoss><e:ProfitLoss contextRef="c1522" unitRef="u5" decimals="0">7707694</e:ProfitLoss><e:Equity contextRef="c1520" unitRef="u5" decimals="0">17318939</e:Equity><e:Equity contextRef="c1523" unitRef="u5" decimals="0">14876424</e:Equity><e:IncreaseDecreaseOfInvestmentsThroughNetExchangeDifferencesEquity contextRef="c1673" unitRef="u5" decimals="0">9428</e:IncreaseDecreaseOfInvestmentsThroughNetExchangeDifferencesEquity><e:IncreaseDecreaseOfInvestmentsThroughNetExchangeDifferencesEquity contextRef="c1676" unitRef="u5" decimals="0">0</e:IncreaseDecreaseOfInvestmentsThroughNetExchangeDifferencesEquity><e:Equity contextRef="c1674" unitRef="u5" decimals="0">9428</e:Equity><e:Equity contextRef="c1677" unitRef="u5" decimals="0">0</e:Equity><e:Equity contextRef="c137" unitRef="u5" decimals="0">-20786062</e:Equity><e:Equity contextRef="c498" unitRef="u5" decimals="0">-8351463</e:Equity><e:ProfitLoss contextRef="c138" unitRef="u5" decimals="0">-16077498</e:ProfitLoss><e:ProfitLoss contextRef="c499" unitRef="u5" decimals="0">-4726905</e:ProfitLoss><e:TransferredFromSharePremium contextRef="c138" unitRef="u5" decimals="0">380754</e:TransferredFromSharePremium><e:TransferredFromSharePremium contextRef="c499" unitRef="u5" decimals="0">0</e:TransferredFromSharePremium><e:ValueAdjustmentsOfEquity contextRef="c138" unitRef="u5" decimals="0">-2442515</e:ValueAdjustmentsOfEquity><e:ValueAdjustmentsOfEquity contextRef="c499" unitRef="u5" decimals="0">-7707694</e:ValueAdjustmentsOfEquity><e:Equity contextRef="c139" unitRef="u5" decimals="0">-38925321</e:Equity><e:Equity contextRef="c500" unitRef="u5" decimals="0">-20786062</e:Equity><g:IdentificationOfApprovedAnnualReport contextRef="c1" xml:lang="da">Direktionen har dags dato aflagt årsrapporten for regnskabsåret 1. oktober 2021 - 30. september 2022 for Celvivo ApS.
</g:IdentificationOfApprovedAnnualReport><g:IdentificationOfApprovedAnnualReport contextRef="c1" xml:lang="en">Today, the Managing Director has approved the annual report of Celvivo ApS for the financial year 1 October 2021 - 30 September 2022.
</g:IdentificationOfApprovedAnnualReport><g:ConfirmationThatAnnualReportIsPresentedInAccordanceWithRequirementsProvidedForByLegislationAnyStandardsAndRequirementsProvidedByArticlesOfAssociationOrByAgreement contextRef="c1" xml:lang="da">Årsrapporten er aflagt i overensstemmelse med årsregnskabsloven.
</g:ConfirmationThatAnnualReportIsPresentedInAccordanceWithRequirementsProvidedForByLegislationAnyStandardsAndRequirementsProvidedByArticlesOfAssociationOrByAgreement><g:ConfirmationThatAnnualReportIsPresentedInAccordanceWithRequirementsProvidedForByLegislationAnyStandardsAndRequirementsProvidedByArticlesOfAssociationOrByAgreement contextRef="c1" xml:lang="en">The annual report has been prepared in accordance with the Danish Financial Statements Act.
</g:ConfirmationThatAnnualReportIsPresentedInAccordanceWithRequirementsProvidedForByLegislationAnyStandardsAndRequirementsProvidedByArticlesOfAssociationOrByAgreement><g:ConfirmationThatFinancialStatementGivesTrueAndFairViewOfAssetsLiabilitiesEquityFinancialPositionAndResults contextRef="c1" xml:lang="da">Jeg anser den valgte regnskabspraksis for hensigtsmæssig, og efter min opfattelse giver årsregnskabet et retvisende billede af selskabets aktiver, passiver og finansielle stilling pr. 30. september 2022 samt af resultatet af selskabets aktiviteter for regnskabsåret 1. oktober 2021 - 30. september 2022.
</g:ConfirmationThatFinancialStatementGivesTrueAndFairViewOfAssetsLiabilitiesEquityFinancialPositionAndResults><g:ConfirmationThatFinancialStatementGivesTrueAndFairViewOfAssetsLiabilitiesEquityFinancialPositionAndResults contextRef="c1" xml:lang="en">I consider the chosen accounting policy to be appropriate, and in my opinion, the financial statements give a true and fair view of the financial position of the Company at 30 September 2022 and of the results of the Company's operations for the financial year 1 October 2021 – 30 September 2022.
</g:ConfirmationThatFinancialStatementGivesTrueAndFairViewOfAssetsLiabilitiesEquityFinancialPositionAndResults><g:ManagementsStatementAboutManagementsReview contextRef="c1" xml:lang="da">Ledelsesberetningen indeholder efter min opfattelse en retvisende redegørelse for de forhold, som beretningen omhandler.
</g:ManagementsStatementAboutManagementsReview><g:ManagementsStatementAboutManagementsReview contextRef="c1" xml:lang="en">Further, in my opinion, the Management's review gives a true and fair review of the matters discussed in the Management's review.
</g:ManagementsStatementAboutManagementsReview><g:RecommendationForApprovalOfAnnualReportByGeneralMeeting contextRef="c1" xml:lang="da">Årsrapporten indstilles til generalforsamlingens godkendelse.
</g:RecommendationForApprovalOfAnnualReportByGeneralMeeting><g:RecommendationForApprovalOfAnnualReportByGeneralMeeting contextRef="c1" xml:lang="en">We recommend that the annual report be approved at the Annual General Meeting.
</g:RecommendationForApprovalOfAnnualReportByGeneralMeeting><d:NameAndSurnameOfMemberOfExecutiveBoard contextRef="c29">Peter Willems-Alnøe</d:NameAndSurnameOfMemberOfExecutiveBoard><f:OpinionOnAuditedFinancialStatements contextRef="c1" xml:lang="da">Vi har revideret årsregnskabet for Celvivo ApS for regnskabsåret 1. oktober 2021 - 30. september 2022, der omfatter resultatopgørelse, balance, egenkapitalopgørelse, noter og anvendt regnskabspraksis. Årsregnskabet udarbejdes efter årsregnskabsloven.

Det er vores opfattelse, at årsregnskabet giver et retvisende billede af selskabets aktiver, passiver og finansielle stilling pr. 30. september 2022 samt af resultatet af selskabets aktiviteter for regnskabsåret 1. oktober 2021 - 30. september 2022 i overensstemmelse med årsregnskabsloven.
</f:OpinionOnAuditedFinancialStatements><f:OpinionOnAuditedFinancialStatements contextRef="c1" xml:lang="en">We have audited the financial statements of Celvivo ApS for the financial year 1 October 2021 - 30 September 2022, which comprise income statement, balance sheet, statement of changes in equity, notes and a summary of significant accounting policies, for the Company. The financial statements are prepared under the Danish Financial Statements Act.

In our opinion, the financial statements give a true and fair view of the financial position of the Company at 30 September 2022, and of the results of the Company's operations for the financial year 1 October 2021 - 30 September 2022 in accordance with the Danish Financial Statements Act.
</f:OpinionOnAuditedFinancialStatements><f:DescriptionOfQualificationsOfAuditedFinancialStatements contextRef="c1" xml:lang="da">Grundlag for konklusion
Vi har udført vores revision i overensstemmelse med internationale standarder om revision og de yderligere krav, der er gældende i Danmark. Vores ansvar ifølge disse standarder og krav er nærmere beskrevet i revisionspåtegningens afsnit ”Revisors ansvar for revisionen af årsregnskabet”. Vi er uafhængige af selskabet i overensstemmelse med International Ethics Standards Board for Accountants' internationale retningslinjer for revisorers etiske adfærd (IESBA Code) og de yderligere etiske krav, der er gældende i Danmark, ligesom vi har opfyldt vores øvrige etiske forpligtelser i henhold til disse krav og IESBA Code. Det er vores opfattelse, at det opnåede revisionsbevis er tilstrækkeligt og egnet som grundlag for vores konklusion.
</f:DescriptionOfQualificationsOfAuditedFinancialStatements><f:DescriptionOfQualificationsOfAuditedFinancialStatements contextRef="c1" xml:lang="en">Basis for Opinion
We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the “Auditor’s Responsibilities for the Audit of the Financial Statements” section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountants’ International Code of Ethics for Professional Accountants (IESBA Code) and the additional ethical requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the IESBA Code. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
</f:DescriptionOfQualificationsOfAuditedFinancialStatements><f:StatementOfExecutiveAndSupervisoryBoardsResponsibilityForFinancialStatements contextRef="c1" xml:lang="da">Ledelsen har ansvaret for udarbejdelsen af et årsregnskab, der giver et retvisende billede i overensstemmelse med årsregnskabsloven. Ledelsen har endvidere ansvaret for den interne kontrol, som ledelsen anser nødvendig for at udarbejde et årsregnskab uden væsentlig fejlinformation, uanset om denne skyldes besvigelser eller fejl.

Ved udarbejdelsen af årsregnskabet er ledelsen ansvarlig for at vurdere selskabets evne til at fortsætte driften; at oplyse om forhold vedrørende fortsat drift, hvor dette er relevant; samt at udarbejde årsregnskabet på grundlag af regnskabsprincippet om fortsat drift, medmindre ledelsen enten har til hensigt at likvidere selskabet, indstille driften eller ikke har andet realistisk alternativ end at gøre dette.
</f:StatementOfExecutiveAndSupervisoryBoardsResponsibilityForFinancialStatements><f:StatementOfExecutiveAndSupervisoryBoardsResponsibilityForFinancialStatements contextRef="c1" xml:lang="en">Management is responsible for the preparation of financial statements that give a true and fair view in accordance with the Danish Financial Statements Act, and for such internal control as Management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, Management is responsible for assessing the Company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting in preparing the financial statements unless Management either intends to liquidate the Company or to cease operations, or has no realistic alternative but to do so.
</f:StatementOfExecutiveAndSupervisoryBoardsResponsibilityForFinancialStatements><f:StatementOfAuditorsResponsibilityForAuditAndAuditPerformed contextRef="c1" xml:lang="da">Vores mål er at opnå høj grad af sikkerhed for, om årsregnskabet som helhed er uden væsentlig fejlinformation, uanset om denne skyldes besvigelser eller fejl, og at afgive en revisionspåtegning med en konklusion. Høj grad af sikkerhed er et højt niveau af sikkerhed, men er ikke en garanti for, at en revision, der udføres i overensstemmelse med internationale standarder om revision og de yderligere krav, der er gældende i Danmark, altid vil afdække væsentlig fejlinformation, når sådan findes. Fejlinformationer kan opstå som følge af besvigelser eller fejl og kan betragtes som væsentlige, hvis det med rimelighed kan forventes, at de enkeltvis eller samlet har indflydelse på de økonomiske beslutninger, som regnskabsbrugerne træffer på grundlag af årsregnskabet.

Som led i en revision, der udføres i overensstemmelse med internationale standarder om revision og de yderligere krav, der er gældende i Danmark, foretager vi faglige vurderinger og opretholder professionel skepsis under revisionen. Herudover:

Identificerer og vurderer vi risikoen for væsentlig fejlinformation i årsregnskabet, uanset om denne skyldes besvigelser eller fejl, udformer og udfører revisionshandlinger som reaktion på disse risici samt opnår revisionsbevis, der er tilstrækkeligt og egnet til at danne grundlag for vores konklusion. Risikoen for ikke at opdage væsentlig fejlinformation forårsaget af besvigelser er højere end ved væsentlig fejlinformation forårsaget af fejl, idet besvigelser kan omfatte sammensværgelser, dokumentfalsk, bevidste udeladelser, vildledning eller tilsidesættelse af intern kontrol.

Opnår vi forståelse af den interne kontrol med relevans for revisionen for at kunne udforme revisionshandlinger, der er passende efter omstændighederne, men ikke for at kunne udtrykke en konklusion om effektiviteten af selskabets interne kontrol.

Tager vi stilling til, om den regnskabspraksis, som er anvendt af ledelsen, er passende, samt om de regnskabsmæssige skøn og tilknyttede oplysninger, som ledelsen har udarbejdet, er rimelige.

Konkluderer vi, om ledelsens udarbejdelse af årsregnskabet på grundlag af regnskabsprincippet om fortsat drift er passende, samt om der på grundlag af det opnåede revisionsbevis er væsentlig usikkerhed forbundet med begivenheder eller forhold, der kan skabe betydelig tvivl om selskabets evne til at fortsætte driften. Hvis vi konkluderer, at der er en væsentlig usikkerhed, skal vi i vores revisionspåtegning gøre opmærksom på oplysninger herom i årsregnskabet eller, hvis sådanne oplysninger ikke er tilstrækkelige, modificere vores konklusion. Vores konklusioner er baseret på det revisionsbevis, der er opnået frem til datoen for vores revisionspåtegning. Fremtidige begivenheder eller forhold kan dog medføre, at selskabet ikke længere kan fortsætte driften.

Tager vi stilling til den samlede præsentation, struktur og indhold af årsregnskabet, herunder noteoplysningerne, samt om årsregnskabet afspejler de underliggende transaktioner og begivenheder på en sådan måde, at der gives et retvisende billede heraf.

Vi kommunikerer med den øverste ledelse om blandt andet det planlagte omfang og den tidsmæssige placering af revisionen samt betydelige revisionsmæssige observationer, herunder eventuelle betydelige mangler i intern kontrol, som vi identificerer under revisionen.
</f:StatementOfAuditorsResponsibilityForAuditAndAuditPerformed><f:StatementOfAuditorsResponsibilityForAuditAndAuditPerformed contextRef="c1" xml:lang="en">Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs and the additional requirements applicable in Denmark will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

As part of an audit conducted in accordance with ISAs and the additional requirements applicable in Denmark, we exercise professional judgment and maintain professional skepticism throughout the audit. We also:

Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control.

Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by Management.

Conclude on the appropriateness of Management’s use of the going concern basis of accounting in preparing the financial statements and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Company’s ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor’s report to the related disclosures in the financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor’s report. However, future events or conditions may cause the Company to cease to continue as a going concern.

Evaluate the overall presentation, structure and contents of the financial statements, including the disclosures, and whether the financial statements represent the underlying transactions and events in a manner that gives a true and fair view.

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.
</f:StatementOfAuditorsResponsibilityForAuditAndAuditPerformed><f:StatementOnManagementsReviewAuditorsReportOnAuditedFinancialStatements contextRef="c1" xml:lang="da">Udtalelse om ledelsesberetningen
Ledelsen er ansvarlig for ledelsesberetningen.

Vores konklusion om årsregnskabet omfatter ikke ledelsesberetningen, og vi udtrykker ingen form for konklusion med sikkerhed om ledelsesberetningen.

I tilknytning til vores revision af årsregnskabet er det vores ansvar at læse ledelsesberetningen og i den forbindelse overveje, om ledelsesberetningen er væsentligt inkonsistent med årsregnskabet eller vores viden opnået ved revisionen eller på anden måde synes at indeholde væsentlig fejlinformation.

Vores ansvar er derudover at overveje, om ledelsesberetningen indeholder krævede oplysninger i henhold til årsregnskabsloven.

Baseret på det udførte arbejde er det vores opfattelse, at ledelsesberetningen er i overensstemmelse med årsregnskabet og er udarbejdet i overensstemmelse med årsregnskabslovens krav. Vi har ikke fundet væsentlig fejlinformation i ledelsesberetningen.
</f:StatementOnManagementsReviewAuditorsReportOnAuditedFinancialStatements><f:StatementOnManagementsReviewAuditorsReportOnAuditedFinancialStatements contextRef="c1" xml:lang="en">Statement on Management’s Review
Management is responsible for Management’s Review.

Our opinion on the financial statements does not cover Management’s Review, and we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read Management’s Review and, in doing so, consider whether Management’s Review is materially inconsistent with the financial statements or our knowledge obtained during the audit, or otherwise appears to be materially misstated.

Moreover, it is our responsibility to consider whether Management’s Review provides the information required under the Danish Financial Statements Act.

Based on the work we have performed, we conclude that Management’s Review is in accordance with the financial statements and has been prepared in accordance with the requirements of the Danish Financial Statement Act. We did not identify any material misstatement of Management’s Review.
</f:StatementOnManagementsReviewAuditorsReportOnAuditedFinancialStatements><h:DescriptionOfPrimaryActivitiesOfEntity contextRef="c1" xml:lang="da">Selskabets væsentligste aktiviteter
Hovedaktiviteten har i lighed med tidligere år bestået af, at drive virksomhed med bioteknologi og hermed forbundet virksomhed.
</h:DescriptionOfPrimaryActivitiesOfEntity><h:DescriptionOfPrimaryActivitiesOfEntity contextRef="c1" xml:lang="en">The principal activities of the company
Like previous years, the principal activities of the company are the operations with biotechnology and related activities. 
</h:DescriptionOfPrimaryActivitiesOfEntity><h:DescriptionOfDevelopmentInActivitiesAndFinancialAffairs contextRef="c1" xml:lang="da">Udvikling i aktiviteter og økonomiske forhold
Årets bruttotab udgør -2.493 t.kr. mod 2.656 t.kr. sidste år. Det ordinære resultat efter skat udgør -16.077 t.kr. mod -4.727 t.kr. sidste år. Ledelsen anser årets resultat som forventet.

Kapitalberedskab
Selskabet har tabt selskabskapitalen og er derfor omfattet af Selskabslovens bestemmelser om kapitaltab. Selskabet har igangværende udviklingsprojekter, der forventes at kunne bidrage med indtjeninger der kan reetablere selskabskapitalen. Dertil er der opnået tilsagn fra modervirksomheden om at opretholde nuværende lånefaciliteter samt bidrage med yderligere finansiering i det kommende år. 
</h:DescriptionOfDevelopmentInActivitiesAndFinancialAffairs><h:DescriptionOfDevelopmentInActivitiesAndFinancialAffairs contextRef="c1" xml:lang="en">Development in activities and financial matters
The gross loss for the year totals DKK -2.493.000 against DKK 2.656.000 last year. Income or loss from ordinary activities after tax totals DKK -16.077.000 against DKK -4.727.000 last year. Management considers the net loss as expected.

Financial resources
The company has lost its share capital and is thus subject to the provisions of the Danish Companies Act on capital losses. The company has in progress development projects. Management expects the development projects to result in earnings that can restore the share capital. In addition, commitments have been made by the parent company to maintain current loan facilities and provide additional financing in the coming year.
</h:DescriptionOfDevelopmentInActivitiesAndFinancialAffairs><e:DisclosureOfUncertaintiesRelatingToGoingConcern contextRef="c1" xml:lang="da">1.
Kapitalforhold
Financial resources
Selskabet har tabt selskabskapitalen og er derfor omfattet af Selskabslovens bestemmelser om kapitaltab. Selskabet har igangværende udviklingsprojekter, der forventes at kunne bidrage med indtjeninger der kan reetablere selskabskapitalen. Dertil er der opnået tilsagn fra modervirksomheden om at opretholde nuværende lånefaciliteter samt bidrage med yderligere finansiering i det kommende år. 
The company has lost its share capital and is thus subject to the provisions of the Danish Companies Act on capital losses. The company has in progress development projects. Management expects the development projects to result in earnings that can restore the share capital. In addition, commitments have been made by the parent company to maintain current loan facilities and provide additional financing in the coming year.


</e:DisclosureOfUncertaintiesRelatingToGoingConcern><e:DisclosureOfContingentLiabilities contextRef="c1" xml:lang="da">14. Eventualposter
Contingencies
Eventualforpligtelser
Contingent liabilities
Huslejeforpligtelse:
Rent liabilities:
Selskabet har indgået huslejeforpligtelser på t.kr. 384 pr. 30. september 2022 svarende til 1-6 måneders husleje.
The company has entered into rent obligations of DKK 384 thousand at 30 September 2022 corresponding to 1-6 months rent.

</e:DisclosureOfContingentLiabilities><e:InformationOnReportingClassOfEntity contextRef="c1" xml:lang="da">Årsrapporten for Celvivo ApS er aflagt i overensstemmelse med årsregnskabslovens bestemmelser for en klasse B-virksomhed. Herudover har virksomheden valgt at følge enkelte regler for klasse C-virksomheder.
</e:InformationOnReportingClassOfEntity><e:InformationOnReportingClassOfEntity contextRef="c1" xml:lang="en">The annual report for Celvivo ApS has been presented in accordance with the Danish Financial Statements Act regulations concerning reporting class B enterprises. Furthermore, the company has decided to comply with certain rules applying to reporting class C enterprises.
</e:InformationOnReportingClassOfEntity><e:DescriptionOfEffectOfChangeInRecognitionAndMeasurementBasisOfAssetsAndLiabilitiesAsResultOfErrors contextRef="c1" xml:lang="da">Ændring i anvendt regnskabspraksis
Selskabet har ændret regnskabspraksis for indregning og måling af kapitalandele. Tidligere anvendte selskabet kostpris og har ændret praksis til indre værdis metode efter konsolideringsmetoden.

Baggrunden for ændringen er, at det vil give et mere retvisende billede af selskabets aktiver og forpligtelser.

Da der ikke var aflagt årsrapport for datterselskabet sidste år, og driftsaktiviteten først er påbegyndt i løbet af indeværende regnskabsår, har ændringen ikke nogen beløbsmæssig indvirkning på årets resultat, balance eller skat i sammenligningstallene. 

Sammenligningstallene er tilpasset den ændrede regnskabspraksis.

Bortset herfra er anvendt regnskabspraksis uændret i forhold til sidste år.
</e:DescriptionOfEffectOfChangeInRecognitionAndMeasurementBasisOfAssetsAndLiabilitiesAsResultOfErrors><e:DescriptionOfEffectOfChangeInRecognitionAndMeasurementBasisOfAssetsAndLiabilitiesAsResultOfErrors contextRef="c1" xml:lang="en">Changes in the accounting policies
The company has changed its accounting policies for the recognition and measurement of equity investments. Previously, the company used cost price and has changed its policy to the equity method according to the consolidation method.

The reason for the change is that it will give a more accurate picture of the company's assets and liabilities.

Since no annual report was submitted for the subsidiary last year, and the operating activity only started during the current financial year, the change has no monetary impact on the year's result, balance sheet or tax in the comparative figures.

The comparative figures have been adjusted to the changed accounting policies.

Except for the above, the accounting policies remain unchanged from last year.
</e:DescriptionOfEffectOfChangeInRecognitionAndMeasurementBasisOfAssetsAndLiabilitiesAsResultOfErrors><e:DescriptionOfGeneralMattersRelatedToRecognitionMeasurementAndChangesInAccountingPolicies contextRef="c1" xml:lang="da">Generelt om indregning og måling
I resultatopgørelsen indregnes indtægter i takt med, at de indtjenes. Herunder indregnes værdireguleringer af finansielle aktiver og forpligtelser. I resultatopgørelsen indregnes ligeledes alle omkostninger, herunder afskrivninger, nedskrivninger og hensatte forpligtelser samt tilbageførsler som følge af ændrede regnskabsmæssige skøn af beløb, der tidligere har været indregnet i resultatopgørelsen.

Aktiver indregnes i balancen, når det er sandsynligt, at fremtidige økonomiske fordele vil tilflyde selskabet, og aktivets værdi kan måles pålideligt.

Forpligtelser indregnes i balancen, når det er sandsynligt, at fremtidige økonomiske fordele vil fragå selskabet, og forpligtelsens værdi kan måles pålideligt.

Ved første indregning måles aktiver og forpligtelser til kostpris. Efterfølgende måles aktiver og forpligtelser som beskrevet nedenfor for hver enkelt regnskabspost.

Ved indregning og måling tages hensyn til forudsigelige tab og risici, der fremkommer inden årsrapporten aflægges, og som vedrører forhold, der eksisterede på balancedagen.
</e:DescriptionOfGeneralMattersRelatedToRecognitionMeasurementAndChangesInAccountingPolicies><e:DescriptionOfGeneralMattersRelatedToRecognitionMeasurementAndChangesInAccountingPolicies contextRef="c1" xml:lang="en">Recognition and measurement in general
Income is recognised in the income statement concurrently with its realisation, including the recognition of value adjustments of financial assets and liabilities. Likewise, all costs are recognised in the income statement, including depreciations amortisations, writedowns for impairment, provisions, and reversals due to changes in estimated amounts previously recognised in the income statement.

Assets are recognised in the statement of financial position when it seems probable that future economic benefits will flow to the company and the value of the asset can be reliably measured.

Liabilities are recognised in the statement of financial position when it is seems probable that future economic benefits will flow out of the company and the value of the liability can be reliably measured.

Assets and liabilities are measured at cost at the initial recognition. Hereafter, assets and liabilities are measured as described below for each individual accounting item.

Upon recognition and measurement, allowances are made for such predictable losses and risks which may arise prior to the presentation of the annual report and concern matters that exist on the reporting date.
</e:DescriptionOfGeneralMattersRelatedToRecognitionMeasurementAndChangesInAccountingPolicies><e:DescriptionOfMethodsOfForeignCurrencies contextRef="c1" xml:lang="da">Omregning af fremmed valuta
Transaktioner i fremmed valuta omregnes til transaktionsdagens kurs. Valutakursdifferencer, der opstår mellem transaktionsdagens kurs og kursen på betalingsdagen, indregnes i resultatopgørelsen som en finansiel post. Hvis valutapositioner anses for sikring af fremtidige pengestrømme, indregnes værdireguleringerne direkte på egenkapitalen i en dagsværdireserve.

Tilgodehavender, gæld og andre monetære poster i fremmed valuta, omregnes til balancedagens valutakurs. Forskellen mellem balancedagens kurs og kursen på tidspunktet for tilgodehavendets eller gældsforpligtelsens opståen eller indregning i seneste årsregnskab indregnes i resultatopgørelsen under finansielle indtægter og omkostninger.

Udenlandske tilknyttede virksomheder anses for at være selvstændige enheder. Resultatopgørelserne omregnes til en gennemsnitlig valutakurs for måneden, og balanceposterne omregnes til balancedagens valutakurser. Kursdifferencer, opstået ved omregning af udenlandske tilknyttede virksomheders egenkapital ved årets begyndelse til balancedagens valutakurser og ved omregning af resultatopgørelser fra gennemsnitskurser til balancedagens valutakurser, indregnes direkte i egenkapitalen i dagsværdireserven. Dette gælder også kursdifferencer, som er opstået ved omregning af resultatopgørelser fra gennemsnitskurser til balancedagens valutakurser.

Kursregulering af mellemværender med udenlandske tilknyttede virksomheder, der anses for en del af den samlede investering i tilknyttede virksomheder, indregnes direkte i egenkapitalen i dagsværdireserven. Tilsvarende indregnes valutakursgevinster og valutakurstab på lån og afledte finansielle instrumenter, som er indgået til kurssikring af selvstændige udenlandske tilknyttede virksomheder, direkte i egenkapitalen.
</e:DescriptionOfMethodsOfForeignCurrencies><e:DescriptionOfMethodsOfForeignCurrencies contextRef="c1" xml:lang="en">Foreign currency translation
Transactions in foreign currency are translated by using the exchange rate prevailing at the date of the transaction. Differences in the rate of exchange arising between the rate at the date of transaction and the rate at the date of payment are recognised in the profit and loss account as an item under net financials. If currency positions are considered to hedge future cash flows, the value adjustments are recognised directly in equity in a fair value reserve.

Receivables, payables, and other foreign currency monetary items are translated using the closing rate. The difference between the closing rate and the rate at the time of the occurrence or initial recognition in the latest financial statements of the receivable or payable is recognised in the income statement under financial income and expenses.

Group enterprises abroad, associates, and equity investments are considered to be independent entities. The income statements are translated at an average exchange rate for the month, and the balance sheet items are translated at the closing rates. Currency translation differences, arising from the translation of the equity of group enterprises abroad at the beginning of the year to the closing rate and from the translation of income statements from average prices to the closing rate, are recognised directly in equity in the fair value reserve. This also applies to differences arising from translation of income statements from average exchange rate to closing rate.

Translation adjustment of balances with group enterprises abroad that are considered part of the total investment in group enterprises are recognised directly in equity in the fair value reserve. Likewise, foreign exchange gains and losses on loans and derived financial instruments for currency hedging independent group enterprises abroad are recognised directly in equity.
</e:DescriptionOfMethodsOfForeignCurrencies><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfRevenue contextRef="c1" xml:lang="da">Bruttotab og andre driftsindtægter
Bruttotab indeholder nettoomsætning, ændring i lagre af færdigvarer og varer under fremstilling, samt eksterne omkostninger.

Nettoomsætning indregnes i resultatopgørelsen, såfremt levering og risikoovergang til køber har fundet sted inden årets udgang, og såfremt indtægten kan opgøres pålideligt og forventes modtaget. Nettoomsætningen indregnes eksklusive moms og afgifter og med fradrag af rabatter i forbindelse med salget.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfRevenue><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfRevenue contextRef="c1" xml:lang="en">Gross loss
Gross loss comprises the revenue, changes in inventories of finished goods, and work in progress and external costs.

Revenue is recognised in the income statement if delivery and passing of risk to the buyer have taken place before the end of the year and if the income can be determined reliably and inflow is anticipated. Recognition of revenue is exclusive of VAT and taxes and less any discounts relating directly to sales.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfRevenue><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfCostOfSales contextRef="c1" xml:lang="da">Vareforbrug omfatter omkostninger til køb af råvarer og hjælpematerialer med fradrag af rabatter samt årets forskydning i varebeholdninger.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfCostOfSales><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfCostOfSales contextRef="c1" xml:lang="en">Cost of sales comprises costs concerning purchase of raw materials and consumables less discounts and changes in inventories.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfCostOfSales><e:DescriptionOfOwnWorkCapitalised contextRef="c1" xml:lang="da">Arbejde udført for egen regning og opført under aktiver
Arbejde udført for egen regning og opført under aktiver omfatter personaleomkostninger og andre interne omkostninger, der er afholdt i regnskabsåret og indregnet i kostprisen for egenudviklede immaterielle og materielle anlægsaktiver.
</e:DescriptionOfOwnWorkCapitalised><e:DescriptionOfOwnWorkCapitalised contextRef="c1" xml:lang="en">Work performed for own account and capitalised
Work performed for own account and capitalised includes staff cost and other internal costs incurred during the financial year and recognised in the cost of proprietary intangible and tangible fixed assets.
</e:DescriptionOfOwnWorkCapitalised><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfOtherOperatingIncome contextRef="c1" xml:lang="da">Andre driftsindtægter indeholder regnskabsposter af sekundær karakter i forhold til virksomhedens hovedaktiviteter.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfOtherOperatingIncome><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfOtherOperatingIncome contextRef="c1" xml:lang="en">Other operating income comprises items of a secondary nature as regards the principal activities of the enterprise.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfOtherOperatingIncome><e:DescriptionOfPublicGrants contextRef="c1" xml:lang="da">Offentlige tilskud
Tilskud til investering/indkøb af aktiver
Tilskud indregnes i balancen under periodeafgrænsningsposter (passiver) og overføres til offentlige tilskud i resultatopgørelsen i takt med afskrivning af de aktiver, tilskuddene vedrører.
</e:DescriptionOfPublicGrants><e:DescriptionOfPublicGrants contextRef="c1" xml:lang="en">Government grants
Grants for investing in/purchasing assets
Grants are recognised in the statement of financial position under prepayments and accrued income (equity and liabilities) and transferred to government grants in the income statement in tandem with the amortisation of the grant-related assets.
</e:DescriptionOfPublicGrants><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfExternalExpenses contextRef="c1" xml:lang="da">Andre eksterne omkostninger omfatter omkostninger til salg, reklame, administration og  lokaler.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfExternalExpenses><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfExternalExpenses contextRef="c1" xml:lang="en">Other external expenses comprise expenses incurred for distribution, sales, advertising, administration and premises.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfExternalExpenses><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfEmployeeBenefitExpense contextRef="c1" xml:lang="da">Personaleomkostninger
Personaleomkostninger omfatter løn og gager, inklusive feriepenge og pensioner samt andre omkostninger til social sikring mv. til selskabets medarbejdere.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfEmployeeBenefitExpense><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfEmployeeBenefitExpense contextRef="c1" xml:lang="en">Staff costs
Staff costs include salaries and wages, including holiday allowances, pensions, and other social security costs, etc., for staff members.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfEmployeeBenefitExpense><e:DescriptionOfMethodsOfImpairmentLossesAndDepreciation contextRef="c1" xml:lang="da">Af- og nedskrivninger
Af- og nedskrivninger indeholder årets af- og nedskrivninger samt fortjeneste og tab ved salg af immaterielle og materielle anlægsaktiver.
</e:DescriptionOfMethodsOfImpairmentLossesAndDepreciation><e:DescriptionOfMethodsOfImpairmentLossesAndDepreciation contextRef="c1" xml:lang="en">Depreciation, amortisation, and writedown for impairment
Depreciation, amortisation, and writedown for impairment comprise depreciation, amortisation, and writedown for the year and profit and loss on the disposal of intangible and tangible assets.
</e:DescriptionOfMethodsOfImpairmentLossesAndDepreciation><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfFinanceIncomeAndExpenses contextRef="c1" xml:lang="da">Finansielle indtægter og omkostninger
Finansielle indtægter og omkostninger indregnes i resultatopgørelsen med de beløb, der vedrører regnskabsåret. Finansielle poster omfatter renteindtægter og -omkostninger og realiserede og urealiserede kursgevinster og kurstab vedrørende transaktioner i fremmed valuta. 
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfFinanceIncomeAndExpenses><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfFinanceIncomeAndExpenses contextRef="c1" xml:lang="en">Financial income and expenses
Financial income and expenses are recognised in the income statement with the amounts concerning the financial year. Financial income and expenses comprise interest income and expenses and realised and unrealised capital gains and losses relating to transactions in foreign currency.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfFinanceIncomeAndExpenses><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfIncomeAndExpensesFromInvestmentsInGroupEnterprisesAndAssociates contextRef="c1" xml:lang="da">Indtægter af kapitalandele i tilknyttede virksomheder
I resultatopgørelsen indregnes den forholdsmæssige andel af de enkelte tilknyttede virksomheders resultat efter skat efter fuld eliminering af intern avance eller tab og fradrag af afskrivning på goodwill og tillæg af negativ goodwill.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfIncomeAndExpensesFromInvestmentsInGroupEnterprisesAndAssociates><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfIncomeAndExpensesFromInvestmentsInGroupEnterprisesAndAssociates contextRef="c1" xml:lang="en">Results from investments in subsidiaries
After full elimination of intercompany profit or loss less amortised consolidated goodwill, the investment in the individual subsidiaries are recognised in the income statement as a proportional share of the subsidiaries' post-tax profit or loss.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfIncomeAndExpensesFromInvestmentsInGroupEnterprisesAndAssociates><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxExpenses contextRef="c1" xml:lang="da">Skat af årets resultat
Årets skat, der består af årets aktuelle selskabsskat og ændring i udskudt skat, indregnes i resultatopgørelsen med den del, der kan henføres til årets resultat, og direkte i egenkapitalen med den del, der kan henføres til posteringer direkte i egenkapitalen. 
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxExpenses><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxExpenses contextRef="c1" xml:lang="en">Tax on net profit or loss for the year
Tax for the year comprises the current income tax for the year and changes in deferred tax and is recognised in the income statement with the share attributable to the net profit or loss for the year and directly in equity with the share attributable to entries directly in equity. 
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxExpenses><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfIntangibleAssets contextRef="c1" xml:lang="da">Immaterielle anlægsaktiver
Udviklingsprojekter, patenter og licenser
Udviklingsomkostninger omfatter omkostninger, lønninger og gager samt afskrivninger, der direkte kan henføres til udviklingsaktiviteter.

Udviklingsprojekter, der er klart definerede og identificerbare, hvor den tekniske gennemførlighed, tilstrækkelige ressourcer og et potentielt fremtidigt marked eller udviklingsmulighed i virksomheden kan påvises, og hvor det er hensigten at fremstille, markedsføre eller anvende projektet, indregnes som immaterielle anlægsaktiver, såfremt kostprisen kan opgøres pålideligt, og der er tilstrækkelig sikkerhed for, at den fremtidige indtjening kan dække produktions-, salgs- og administrationsomkostninger. Øvrige udviklingsomkostninger indregnes i resultatopgørelsen, efterhånden som omkostningerne afholdes.

Udviklingsomkostninger, der er indregnet i balancen, måles til kostpris med fradrag af akkumulerede af- og nedskrivninger.

Efter færdiggørelsen af udviklingsarbejdet afskrives aktiverede udviklingsomkostninger lineært over den vurderede økonomiske brugstid. 

Patenter og licenser måles til kostpris med fradrag af akkumulerede af- og nedskrivninger. Patenter afskrives lineært over den resterende patentperiode, og licenser afskrives over aftaleperioden, dog maksimalt 5 år.

Fortjeneste og tab ved salg af udviklingsprojekter, patenter og licenser opgøres som forskellen mellem salgsprisen med fradrag af salgsomkostninger og den regnskabsmæssige værdi på salgstidspunktet. Fortjeneste eller tab indregnes i resultatopgørelsen under af- og nedskrivninger.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfIntangibleAssets><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfIntangibleAssets contextRef="c1" xml:lang="en">Intangible assets
Development projects, patents, and licences
Development costs comprise salaries, wages, and amortisation directly attributable to development activities.

Clearly defined and identifiable development projects are recognised as intangible assets provided that they are proven to be technically practicable, that sufficient resources and a potential market or development opportunity exist, and insofar as the intention is to produce, market or utilise the project. It is, however, a condition that the cost can be reliably calculated and that a sufficiently high degree of certainty indicates that future earnings will cover the costs of production, sales, and administration. Other development costs are recognised in the income statement concurrently with their realisation.

Development costs recognised in the statement of financial position are measured at cost less accrued amortisations and writedowns for impairment.

After completion of the development work, capitalised development costs are amortised on a straight-line basis over the estimated useful economic life. 

Patents and licenses are measured at cost less accrued amortisation. Patents are amortised on a straightline basis over the remaining patent period and licenses are amortised over the contract period, however, for a maximum of 5 years.

Profit and loss from the sale of development projects, patents, and licenses are measured as the difference between the sales price less sales costs and the carrying amount at the time of sale. Profit or loss is recognised in the income statement under amortisation and writedown for impairment.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfIntangibleAssets><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfPropertyPlantAndEquipment contextRef="c1" xml:lang="da">Materielle anlægsaktiver
Materielle anlægsaktiver måles til kostpris med fradrag af akkumulerede afskrivninger og nedskrivninger.

Afskrivningsgrundlaget er kostpris med fradrag af eventuel forventet restværdi efter afsluttet brugstid. Afskrivningsperioden og restværdien fastsættes på anskaffelsestidspunktet og revurderes årligt. Overstiger restværdien aktivets regnskabsmæssige værdi, ophører afskrivningen.

Ved ændring i afskrivningsperioden eller restværdien indregnes virkningen for afskrivninger fremover som en ændring i regnskabsmæssigt skøn.

Kostprisen omfatter anskaffelsesprisen samt omkostninger direkte tilknyttet anskaffelsen indtil det tidspunkt, hvor aktivet er klar til at blive taget i brug.

Kostprisen på et samlet aktiv opdeles i separate bestanddele, der afskrives hver for sig, hvor brugstiden på de enkelte bestanddele er forskellig, og den enkelte bestanddel udgør en væsentlig del af den samlede kostpris.

Der foretages lineære afskrivninger baseret på følgende vurdering af aktivernes forventede brugstider og restværdier:

Andre anlæg, driftsmateriel og inventar Brugstid 5 år Restværdi 0%
Småaktiver med en forventet levetid under 1 år indregnes i anskaffelsesåret som omkostninger i resultatopgørelsen.

Fortjeneste eller tab ved afhændelse af materielle anlægsaktiver opgøres som forskellen mellem salgspris med fradrag af salgsomkostninger og den regnskabsmæssige værdi på salgstidspunktet. Fortjeneste eller tab indregnes i resultatopgørelsen under af- og nedskrivninger.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfPropertyPlantAndEquipment><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfPropertyPlantAndEquipment contextRef="c1" xml:lang="en">Property, plant, and equipment
Property, plant, and equipment are measured at cost less accrued depreciation and writedown for impairment.

The depreciable amount is cost less any expected residual value after the end of the useful life of the asset. The amortisation period and the residual value are determined at the acquisition date and reassessed annually. If the residual value exceeds the carrying amount, the depreciation is discontinued.

If the amortisation period or the residual value is changed, the effect on amortisation will, in future, be recognised as a change in the accounting estimates.

The cost comprises acquisition cost and costs directly associated with the acquisition until the time when the asset is ready for use.

The cost of a total asset is divided into separate components. These components are depreciated separately, the useful lives of each individual components differing, and the individual component representing a material part of the total cost.

Depreciation is done on a straight-line basis according to an assessment of the expected useful life  and the residual value of the individual assets:

Other fixtures and fittings, tools and equipment Useful life 5 years Residual value 0%
Minor assets with an expected useful life of less than 1 year are recognised as costs in the income statement in the year of acquisition.

Profit or loss derived from the disposal of property, land, and equipment is measured as the difference between the sales price less selling costs and the carrying amount at the date of disposal. Profit or loss is recognised in the income statement under depreciation.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfPropertyPlantAndEquipment><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfLeaseholdImprovements contextRef="c1" xml:lang="da">Indretning af lejede lokaler
Indretning af lejede lokaler måles til kostpris med fradrag af akkumulerede afskrivninger. Der foretages lineære afskrivninger baseret på vurdering af aktivets forventede brugstid, der er sat til 5 år.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfLeaseholdImprovements><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfLeaseholdImprovements contextRef="c1" xml:lang="en">Leasehold improvements
Leasehold improvements are measured at cost less accrued depreciations. Depreciation is done on a straightline basis over the estimated useful life of the asset, which is set at 5 years.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfLeaseholdImprovements><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisForInvestmentsInSubsidiariesAndAssociates contextRef="c1" xml:lang="da">Kapitalandele i tilknyttede virksomheder
Kapitalandele i tilknyttede virksomheder indregnes og måles efter den indre værdis metode. Indre værdis metode anvendes som en konsolideringsmetode.

I balancen indregnes kapitalandele i tilknyttede virksomheder til den forholdsmæssige andel af virksomhedens regnskabsmæssige indre værdi. Denne opgøres efter modervirksomhedens regnskabspraksis med fradrag eller tillæg af urealiserede koncerninterne avancer og tab samt med tillæg eller fradrag af resterende værdi af positiv eller negativ goodwill opgjort efter overtagelsesmetoden. Negativ goodwill indregnes i resultatopgørelsen ved købet af kapitalandelen. Vedrører den negative goodwill overtagne eventualforpligtelser, indtægtsføres negativ goodwill først, når eventualforpligtelserne er afviklet eller bortfaldet.

Kapitalandele i tilknyttede virksomheder med regnskabsmæssig negativ indre værdi måles til 0 kr., og et eventuelt tilgodehavende hos disse virksomheder nedskrives, i det omfang tilgodehavendet er uerholdeligt. I det omfang modervirksomheden har en retlig eller faktisk forpligtelse til at dække en underbalance, der overstiger tilgodehavendet, indregnes det resterende beløb under hensatte forpligtelser.

Nettoopskrivning af kapitalandele i tilknyttede virksomheder overføres under egenkapitalen til reserve for nettoopskrivning efter den indre værdis metode i det omfang, den regnskabsmæssige værdi overstiger kostprisen. Udbytter fra tilknyttede virksomheder, der forventes vedtaget inden godkendelsen af nærværende årsrapport, bindes ikke på opskrivningsreserven. Reserven reguleres med andre egenkapitalbevægelser i tilknyttede virksomheder.

Nyerhvervede eller nystiftede virksomheder indregnes i årsregnskabet fra anskaffelsestidspunktet. Solgte eller afviklede virksomheder indregnes frem til afståelsestidspunktet.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisForInvestmentsInSubsidiariesAndAssociates><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisForInvestmentsInSubsidiariesAndAssociates contextRef="c1" xml:lang="en">Investments in subsidiaries
Investments in subsidiaries are recognised and measured by applying the equity method. The equity method is used as a method of consolidation.

Investments in subsidiaries are recognised in the statement of financial position at the proportionate share of the enterprise's equity value. This value is calculated in accordance with the parent's accounting policies with deductions or additions of unrealised intercompany gains and losses as well as with additions or deductions of the remaining value of positive or negative goodwill calculated in accordance with the acquisition method. Negative goodwill is recognised in the income statement at the time of acquisition of the equity investment. If the negative goodwill relates to contingent liabilities acquired, negative goodwill is not recognised until the contingent liabilities have been settled or lapsed.

Investments in subsidiaries with a negative equity value are measured at DKK 0, and any accounts receivable from these enterprises are written down to the extent that the account receivable is uncollectible. To the extent that the parent has a legal or constructive obligation to cover an negative balance that exceeds the account receivable, the remaining amount is recognised under provisions.

To the extent the equity exceeds the cost, the net revaluation of equity investments in subsidiaries  transferred to the reserve under equity for net revaluation according to the equity method. Dividends from subsidiaries expected to be adopted before the approval of this annual report are not subject to a limitation of the revaluation reserve. The reserve is adjusted by other equity movements in subsidiaries.

Newly acquired or newly established companies are recognised in the financial statement as of the time of acquisition. Sold or liquidated companies are recognised until the date of disposal.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisForInvestmentsInSubsidiariesAndAssociates><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfInvestments contextRef="c1" xml:lang="da">Deposita
Deposita måles til amortiseret kostpris og udgøres af huslejedeposita mv.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfInvestments><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfInvestments contextRef="c1" xml:lang="en">Deposits
Deposits are measured at amortised cost and represent lease deposits, etc.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfInvestments><e:DescriptionOfMethodsOfAmortisationOfNoncurrentAssets contextRef="c1" xml:lang="da">Nedskrivning på anlægsaktiver
Den regnskabsmæssige værdi af såvel immaterielle som materielle anlægsaktiver samt kapitalandele i tilknyttede virksomheder vurderes årligt for indikationer på værdiforringelse ud over det, som udtrykkes ved afskrivning.

Foreligger der indikationer på værdiforringelse, foretages nedskrivningstest af hvert enkelt aktiv henholdsvis gruppe af aktiver. Der foretages nedskrivning til genindvindingsværdien, såfremt denne er lavere end den regnskabsmæssige værdi.

Genindvindingsværdien er den højeste værdi af kapitalværdi og salgsværdi fratrukket forventede omkostninger ved et salg. Kapitalværdien opgøres som nutidsværdien af de forventede nettopengestrømme fra anvendelsen af aktivet eller aktivgruppen og forventede nettopengestrømme ved salg af aktivet eller aktivgruppen efter endt brugstid.

Tidligere indregnede nedskrivninger tilbageføres, når betingelsen for nedskrivningen ikke længere består. 
</e:DescriptionOfMethodsOfAmortisationOfNoncurrentAssets><e:DescriptionOfMethodsOfAmortisationOfNoncurrentAssets contextRef="c1" xml:lang="en">Impairment loss relating to non-current assets
The carrying amount of both intangible and tangible fixed assets as well as equity investments in subsidiaries are subject to annual impairment tests in order to disclose any indications of impairment beyond those expressed by amortisation and depreciation respectively.

If indications of impairment are disclosed, impairment tests are carried out for each individual asset or group of assets, respectively. Writedown for impairment is done to the recoverable amount if this value is lower than the carrying amount.

The recoverable amount is the higher value of value in use and selling price less expected selling cost. The value in use is calculated as the present value of the expected net cash flows from the use of the asset or the asset group and expected net cash flows from the sale of the asset or the asset group after the end of their useful life.

Previously recognised impairment losses are reversed when conditions for impairment no longer exist. 
</e:DescriptionOfMethodsOfAmortisationOfNoncurrentAssets><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfInventories contextRef="c1" xml:lang="da">Varebeholdninger
Varebeholdninger måles til kostpris efter FIFO-metoden. Er nettorealisationsværdien af varebeholdninger lavere end kostprisen, nedskrives til denne lavere værdi.

Kostpris for handelsvarer samt råvarer og hjælpematerialer omfatter anskaffelsespris med tillæg af hjemtagelsesomkostninger.

Kostpris for fremstillede færdigvarer og varer under fremstilling omfatter kostpris for råvarer, hjælpematerialer, direkte løn og indirekte produktionsomkostninger. Indirekte produktionsomkostninger indeholder indirekte materialer og løn samt vedligeholdelse af og afskrivning på maskiner, fabriksbygninger og udstyr, der benyttes i produktionsprocessen, samt omkostninger til fabriksadministration og fabriksledelse. Låneomkostninger indregnes ikke i kostprisen.

Nettorealisationsværdien for varebeholdninger opgøres som salgssum med fradrag af såvel færdiggørelsesomkostninger som omkostninger, der afholdes for at effektuere salget. Nettorealisationsværdien fastsættes under hensyntagen til omsættelighed, kurans og udvikling i forventet salgspris.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfInventories><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfInventories contextRef="c1" xml:lang="en">Inventories
Inventories are measured at cost according to the FIFO method. In cases when the net realisable value of the inventories is lower than the cost, the latter is written down for impairment to this lower value.

Costs of goods for resale, raw materials, and consumables comprise acquisition costs plus delivery costs.

Costs of manufactured goods and work in progress comprise the cost of raw materials, consumables, direct wages, and indirect production costs. Indirect production costs comprise indirect materials and wages, maintenance and depreciation of machinery, factory buildings, and equipment used in the production process, and costs for factory administration and factory management. Borrowing expenses are not recognised in cost.

The net realisable value for inventories is recognised as the market price less costs of completion and selling costs. The net realisable value is determined with due consideration of negotiability, obsolescence, and the development of expected market prices.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfInventories><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfReceivables contextRef="c1" xml:lang="da">Tilgodehavender
Tilgodehavender måles til amortiseret kostpris, hvilket sædvanligvis svarer til nominel værdi.

Der nedskrives til nettorealisationsværdien med henblik på at imødegå forventede tab. 
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfReceivables><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfReceivables contextRef="c1" xml:lang="en">Receivables
Receivables are measured at amortised cost, which usually corresponds to nominal value.

In order to meet expected losses, impairment takes place at the net realisable value. 
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfReceivables><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfDeferredIncomeAssets contextRef="c1" xml:lang="da">Periodeafgrænsningsposter
Periodeafgrænsningsposter, som er indregnet under aktiver, omfatter afholdte omkostninger vedrørende efterfølgende regnskabsår.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfDeferredIncomeAssets><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfDeferredIncomeAssets contextRef="c1" xml:lang="en">Prepayments
Prepaymentsrecognised under assets comprise incurred costs concerning the following financial year.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfDeferredIncomeAssets><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfCashAndCashEquivalents contextRef="c1" xml:lang="da">Likvide beholdninger
Likvide beholdninger omfatter indeståender i pengeinstitutter og kontantbeholdninger.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfCashAndCashEquivalents><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfCashAndCashEquivalents contextRef="c1" xml:lang="en">Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfCashAndCashEquivalents><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfEquity contextRef="c1" xml:lang="da">Egenkapital
Overkurs ved emission
Overkurs ved emission omfatter beløb, der er indbetalt som overkurs i henhold til tegning af kapitalandele. Omkostninger ved en gennemført emission fradrages i overkursbeløbet.

Overkursreserven kan benyttes til udbytte, fondsemission og dækning af underskud.

Reserve for nettoopskrivning efter den indre værdis metode
Reserve for nettoopskrivning efter indre værdis metode omfatter nettoopskrivning af kapitalandele i tilknyttede virksomheder i forhold til kostpris.

Reserven kan elimineres ved underskud, realisation af kapitalandele eller ændring i regnskabsmæssige skøn.

Reserven kan ikke indregnes med et negativt beløb.

Reserve for udviklingsomkostninger
Reserve for udviklingsomkostninger omfatter indregnede udviklingsomkostninger med fradrag af tilknyttede udskudte skatteforpligtelser.

Reserven kan ikke benyttes til udbytte eller dækning af underskud.

Reserven reduceres eller opløses, hvis de indregnede udviklingsomkostninger afskrives eller udgår af virksomhedens drift. Dette sker ved overførsel direkte til egenkapitalens frie reserver.

Reserve for valutakursomregning
Reserve for valutakursomregning opstår ved omregning af regnskabsposter i udenlandsk valuta.

Reserven opløses samtidig med, at værdireguleringerne realiseres eller tilbageføres.

Reserven er ikke bunden.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfEquity><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfEquity contextRef="c1" xml:lang="en">Equity
Share premium
Share premium comprises premium payments made in connection with the issue of shares. Costs incurred for carrying through an issue are deducted from the premium.

The premium reserve can be used for dividend, for issuing bonus shares, and for covering losses.

Reserve for net revaluation according to the equity method
The reserve for net revaluation according to the equity method comprises net revaluation of equity investments in subsidiaries, associates and equity interests proportional to cost.

The reserve may be eliminated in the event of losses, realisation of equity investments, or changes in the accounting estimates.

The reserve cannot be recognised by a negative amount.

Reserve for development costs
The reserve for development costs comprises recognised development costs less related deferred tax liabilities.

The reserve cannot be used as dividends or for covering losses.

The reserve is reduced or dissolved if the recognised development costs are amortised or abandoned. This is done by direct transfer to the distributable reserves of the equity.

Reserve for foreign currency translation
The reserve for foreign currency translation arises when translating accounting items in foreign currency.

The reserve is dissolved once the value adjustments have been applied or reversed.

The reserve is distributable.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfEquity><e:DescriptionOfMethodsOfDividends contextRef="c1" xml:lang="da">Udbytte
Udbytte, som forventes udbetalt for året, vises som en særskilt post under egenkapitalen.
</e:DescriptionOfMethodsOfDividends><e:DescriptionOfMethodsOfDividends contextRef="c1" xml:lang="en">Dividend
Dividend expected to be distributed for the year is recognised as a separate item under equity.
</e:DescriptionOfMethodsOfDividends><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxPayablesAndDeferredTax contextRef="c1" xml:lang="da">Selskabsskat og udskudt skat
Aktuelle skatteforpligtelser og tilgodehavende aktuel skat indregnes i balancen som beregnet skat af årets skattepligtige indkomst, reguleret for skat af tidligere års skattepligtige indkomster og for betalte acontoskatter.

Udskudt skat måles efter den balanceorienterede gældsmetode af midlertidige forskelle mellem regnskabsmæssig og skattemæssig værdi af aktiver og forpligtelser opgjort på grundlag af den planlagte anvendelse af aktivet henholdsvis afvikling af forpligtelsen. Udskudt skat måles til nettorealisationsværdi.

Udskudt skat måles på grundlag af de skatteregler og skattesatser i de respektive lande, der med balancedagens lovgivning vil være gældende, når den udskudte skat forventes udløst som aktuel skat. Ændring i udskudt skat som følge af ændringer i skattesatser indregnes i resultatopgørelsen bortset fra poster, der føres direkte på egenkapitalen.

Udskudte skatteaktiver, herunder skatteværdien af fremførselsberettiget skattemæssigt underskud, måles til den værdi, hvortil aktivet forventes at kunne realiseres, enten ved udligning i skat af fremtidig indtjening eller ved modregning i udskudte skatteforpligtelser inden for samme juridiske skatteenhed. Eventuelle udskudte nettoskatteaktiver måles til nettorealisationsværdi.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxPayablesAndDeferredTax><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxPayablesAndDeferredTax contextRef="c1" xml:lang="en">Income tax and deferred tax
Current tax liabilities and current tax receivable are recognised in the statement of financial position as calculated tax on the taxable income for the year, adjusted for tax of previous years' taxable income and for tax paid on account.

Deferred tax is measured on the basis of temporary differences in assets and liabilities with a focus on the statement of financial position. Deferred tax is measured at net realisable value.

Deferred tax is measured based on the tax rules and tax rates applying under the legislation prevailing in the respective countries on the reporting date when the deferred tax is expected to be released as current tax. Changes in deferred tax due to changed tax rates are recognised in the income statement, except for items included directly in the equity.

Deferred tax assets, including the tax value of tax losses allowed for carryforward, are recognised at the value at which they are expected to be realisable, either by settlement against tax of future earnings or by set-off in deferred tax liabilities within the same legal tax unit. Any deferred net tax assets are measured at net realisable value.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxPayablesAndDeferredTax><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfLiabilitiesOtherThanProvisions contextRef="c1" xml:lang="da">Gældsforpligtelser
Øvrige gældsforpligtelser, som omfatter gæld til leverandører, tilknyttede virksomheder samt anden gæld, måles til amortiseret kostpris, hvilket sædvanligvis svarer til nominel værdi.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfLiabilitiesOtherThanProvisions><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfLiabilitiesOtherThanProvisions contextRef="c1" xml:lang="en">Liabilities other than provisions
Other liabilities concerning payables to suppliers, group enterprises, and other payables are measured at amortised cost which usually corresponds to the nominal value.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfLiabilitiesOtherThanProvisions><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfDeferredIncomeLiabilities contextRef="c1" xml:lang="da">Periodeafgrænsningsposter
Under periodeafgrænsningsposter indregnes modtagne betalinger vedrørende indtægter i de efterfølgende år.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfDeferredIncomeLiabilities><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfDeferredIncomeLiabilities contextRef="c1" xml:lang="en">Deferred income
Payments received concerning future income are recognised under deferred income.
</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfDeferredIncomeLiabilities><!--Aktuelle periode enkelt selskab--><context id="c1"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><startDate>2021-10-01</startDate><endDate>2022-09-30</endDate></period></context><!--Forrige periode enkelt selskab--><context id="c2"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><startDate>2020-10-01</startDate><endDate>2021-09-30</endDate></period></context><!--Slutdato forrige periode enkelt selskab--><context id="c3"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><instant>2021-09-30</instant></period></context><!--Slutdato aktuelle periode enkelt selskab--><context id="c4"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><instant>2022-09-30</instant></period></context><!--CEO1--><context id="c29"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><startDate>2021-10-01</startDate><endDate>2022-09-30</endDate></period><scenario><xbrldi:typedMember dimension="d:IdentificationOfMemberOfExecutiveBoardDimension"><d:memberOfBoardIdentifier>1</d:memberOfBoardIdentifier></xbrldi:typedMember></scenario></context><!--REVISOR1--><context id="c37"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><startDate>2021-10-01</startDate><endDate>2022-09-30</endDate></period><scenario><xbrldi:typedMember dimension="d:IdentificationOfAuditorDimension"><d:auditorIdentifier>1</d:auditorIdentifier></xbrldi:typedMember></scenario></context><!--UdvProjekt_U_Udforelse aktuel primo--><context id="c42"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><instant>2021-10-01</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfIntangibleAssetsDimension">e:DevelopmentProjectsInProgressMember</xbrldi:explicitMember></scenario></context><!--UdvProjekt_U_Udforelse aktuel i aaret--><context id="c46"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><startDate>2021-10-01</startDate><endDate>2022-09-30</endDate></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfIntangibleAssetsDimension">e:DevelopmentProjectsInProgressMember</xbrldi:explicitMember></scenario></context><!--UdvProject aktuel i aaret--><context id="c52"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><startDate>2021-10-01</startDate><endDate>2022-09-30</endDate></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfIntangibleAssetsDimension">e:CompletedDevelopmentProjectsMember</xbrldi:explicitMember></scenario></context><!--UdvProject aktuel ultimo--><context id="c53"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><instant>2022-09-30</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfIntangibleAssetsDimension">e:CompletedDevelopmentProjectsMember</xbrldi:explicitMember></scenario></context><!--Overfoert resultat aktuel i aaret--><context id="c63"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><startDate>2021-10-01</startDate><endDate>2022-09-30</endDate></period><scenario><xbrldi:explicitMember dimension="e:ResultDistributionDimension">e:RetainedEarningsMember</xbrldi:explicitMember></scenario></context><!--Overfoert resultat forrige i aaret--><context id="c64"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><startDate>2020-10-01</startDate><endDate>2021-09-30</endDate></period><scenario><xbrldi:explicitMember dimension="e:ResultDistributionDimension">e:RetainedEarningsMember</xbrldi:explicitMember></scenario></context><!--Andre anlag aktuel primo--><context id="c99"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><instant>2021-10-01</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfPropertyPlantAndEquipmentDimension">e:FixturesFittingsToolsAndEquipmentMember</xbrldi:explicitMember></scenario></context><!--Andre anlag aktuel i aaret--><context id="c100"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><startDate>2021-10-01</startDate><endDate>2022-09-30</endDate></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfPropertyPlantAndEquipmentDimension">e:FixturesFittingsToolsAndEquipmentMember</xbrldi:explicitMember></scenario></context><!--Andre anlag aktuel ultimo--><context id="c101"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><instant>2022-09-30</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfPropertyPlantAndEquipmentDimension">e:FixturesFittingsToolsAndEquipmentMember</xbrldi:explicitMember></scenario></context><!--Indretning lokaler aktuel primo--><context id="c105"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><instant>2021-10-01</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfPropertyPlantAndEquipmentDimension">e:LeaseholdImprovementsMember</xbrldi:explicitMember></scenario></context><!--Indretning lokaler aktuel i aaret--><context id="c106"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><startDate>2021-10-01</startDate><endDate>2022-09-30</endDate></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfPropertyPlantAndEquipmentDimension">e:LeaseholdImprovementsMember</xbrldi:explicitMember></scenario></context><!--Indretning lokaler aktuel ultimo--><context id="c107"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><instant>2022-09-30</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfPropertyPlantAndEquipmentDimension">e:LeaseholdImprovementsMember</xbrldi:explicitMember></scenario></context><!--Kapandele tilknyttede aktuel primo--><context id="c113"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><instant>2021-10-01</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfInvestmentsDimension">e:InvestmentsInGroupEnterprisesMember</xbrldi:explicitMember></scenario></context><!--Kapandele tilknyttede forrige primo--><context id="c114"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><instant>2020-10-01</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfInvestmentsDimension">e:InvestmentsInGroupEnterprisesMember</xbrldi:explicitMember></scenario></context><!--Kapandele tilknyttede aktuel i aaret--><context id="c115"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><startDate>2021-10-01</startDate><endDate>2022-09-30</endDate></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfInvestmentsDimension">e:InvestmentsInGroupEnterprisesMember</xbrldi:explicitMember></scenario></context><!--Kapandele tilknyttede forrige i aaret--><context id="c116"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><startDate>2020-10-01</startDate><endDate>2021-09-30</endDate></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfInvestmentsDimension">e:InvestmentsInGroupEnterprisesMember</xbrldi:explicitMember></scenario></context><!--Kapandele tilknyttede aktuel ultimo--><context id="c117"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><instant>2022-09-30</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfInvestmentsDimension">e:InvestmentsInGroupEnterprisesMember</xbrldi:explicitMember></scenario></context><!--Kapandele tilknyttede forrige ultimo--><context id="c118"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><instant>2021-09-30</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfInvestmentsDimension">e:InvestmentsInGroupEnterprisesMember</xbrldi:explicitMember></scenario></context><!--Virksomhedskapital aktuel primo--><context id="c119"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><instant>2021-10-01</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ContributedCapitalMember</xbrldi:explicitMember></scenario></context><!--Virksomhedskapital aktuel i aaret--><context id="c120"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><startDate>2021-10-01</startDate><endDate>2022-09-30</endDate></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ContributedCapitalMember</xbrldi:explicitMember></scenario></context><!--Virksomhedskapital aktuel ultimo--><context id="c121"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><instant>2022-09-30</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ContributedCapitalMember</xbrldi:explicitMember></scenario></context><!--Overkurs emission aktuel primo--><context id="c122"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><instant>2021-10-01</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:SharePremiumMember</xbrldi:explicitMember></scenario></context><!--Overkurs emission aktuel i aaret--><context id="c123"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><startDate>2021-10-01</startDate><endDate>2022-09-30</endDate></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:SharePremiumMember</xbrldi:explicitMember></scenario></context><!--Overkurs emission aktuel ultimo--><context id="c124"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><instant>2022-09-30</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:SharePremiumMember</xbrldi:explicitMember></scenario></context><!--Overfort res aktuel primo--><context id="c137"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><instant>2021-10-01</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:RetainedEarningsMember</xbrldi:explicitMember></scenario></context><!--Overfort res aktuel i aaret--><context id="c138"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><startDate>2021-10-01</startDate><endDate>2022-09-30</endDate></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:RetainedEarningsMember</xbrldi:explicitMember></scenario></context><!--Overfort res aktuel ultimo--><context id="c139"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><instant>2022-09-30</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:RetainedEarningsMember</xbrldi:explicitMember></scenario></context><!--Erhverv_immat aktuel primo--><context id="c231"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><instant>2021-10-01</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfIntangibleAssetsDimension">e:AcquiredIntangibleAssetsMember</xbrldi:explicitMember></scenario></context><!--Erhverv_immat aktuel i aaret--><context id="c232"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><startDate>2021-10-01</startDate><endDate>2022-09-30</endDate></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfIntangibleAssetsDimension">e:AcquiredIntangibleAssetsMember</xbrldi:explicitMember></scenario></context><!--Erhverv_immat aktuel ultimo--><context id="c233"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><instant>2022-09-30</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfIntangibleAssetsDimension">e:AcquiredIntangibleAssetsMember</xbrldi:explicitMember></scenario></context><!--Virksomhedskapital forrige EKprimo--><context id="c478"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><instant>2020-10-01</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ContributedCapitalMember</xbrldi:explicitMember></scenario></context><!--Virksomhedskapital forrige EKi aaret--><context id="c479"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><startDate>2020-10-01</startDate><endDate>2021-09-30</endDate></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ContributedCapitalMember</xbrldi:explicitMember></scenario></context><!--Virksomhedskapital forrige EKultimo--><context id="c480"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><instant>2021-09-30</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ContributedCapitalMember</xbrldi:explicitMember></scenario></context><!--Overkurs emission forrige EKprimo--><context id="c484"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><instant>2020-10-01</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:SharePremiumMember</xbrldi:explicitMember></scenario></context><!--Overkurs emission forrige EKi aaret--><context id="c485"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><startDate>2020-10-01</startDate><endDate>2021-09-30</endDate></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:SharePremiumMember</xbrldi:explicitMember></scenario></context><!--Overkurs emission forrige EKultimo--><context id="c486"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><instant>2021-09-30</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:SharePremiumMember</xbrldi:explicitMember></scenario></context><!--Overfort res forrige EKprimo--><context id="c498"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><instant>2020-10-01</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:RetainedEarningsMember</xbrldi:explicitMember></scenario></context><!--Overfort res forrige EKi aaret--><context id="c499"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><startDate>2020-10-01</startDate><endDate>2021-09-30</endDate></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:RetainedEarningsMember</xbrldi:explicitMember></scenario></context><!--Overfort res forrige EKultimo--><context id="c500"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><instant>2021-09-30</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:RetainedEarningsMember</xbrldi:explicitMember></scenario></context><!--Deposita aktuel primo--><context id="c1013"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><instant>2021-10-01</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfInvestmentsDimension">e:DepositsLongtermInvestmentsAndReceivablesMember</xbrldi:explicitMember></scenario></context><!--Deposita aktuel i aaret--><context id="c1014"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><startDate>2021-10-01</startDate><endDate>2022-09-30</endDate></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfInvestmentsDimension">e:DepositsLongtermInvestmentsAndReceivablesMember</xbrldi:explicitMember></scenario></context><!--Deposita aktuel ultimo--><context id="c1015"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><instant>2022-09-30</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfInvestmentsDimension">e:DepositsLongtermInvestmentsAndReceivablesMember</xbrldi:explicitMember></scenario></context><!--Reserve for udviklingsomkostninger aktuel primo--><context id="c1518"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><instant>2021-10-01</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ReserveForDevelopmentExpenditureMember</xbrldi:explicitMember></scenario></context><!--Reserve for udviklingsomkostninger aktuel i aaret--><context id="c1519"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><startDate>2021-10-01</startDate><endDate>2022-09-30</endDate></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ReserveForDevelopmentExpenditureMember</xbrldi:explicitMember></scenario></context><!--Reserve for udviklingsomkostninger aktuel ultimo--><context id="c1520"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><instant>2022-09-30</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ReserveForDevelopmentExpenditureMember</xbrldi:explicitMember></scenario></context><!--Reserve for udviklingsomkostninger forrige primo--><context id="c1521"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><instant>2020-10-01</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ReserveForDevelopmentExpenditureMember</xbrldi:explicitMember></scenario></context><!--Reserve for udviklingsomkostninger forrige i aaret--><context id="c1522"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><startDate>2020-10-01</startDate><endDate>2021-09-30</endDate></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ReserveForDevelopmentExpenditureMember</xbrldi:explicitMember></scenario></context><!--Reserve for udviklingsomkostninger forrige ultimo--><context id="c1523"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><instant>2021-09-30</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ReserveForDevelopmentExpenditureMember</xbrldi:explicitMember></scenario></context><!--Reserve dagsvaerdi valuta aktuel i aaret--><context id="c1673"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><startDate>2021-10-01</startDate><endDate>2022-09-30</endDate></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ReserveForCurrentValueAdjustmentsOfCurrencyGainsMember</xbrldi:explicitMember></scenario></context><!--Reserve dagsvaerdi valuta aktuel ultimo--><context id="c1674"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><instant>2022-09-30</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ReserveForCurrentValueAdjustmentsOfCurrencyGainsMember</xbrldi:explicitMember></scenario></context><!--Reserve dagsvaerdi valuta forrige i aaret--><context id="c1676"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><startDate>2020-10-01</startDate><endDate>2021-09-30</endDate></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ReserveForCurrentValueAdjustmentsOfCurrencyGainsMember</xbrldi:explicitMember></scenario></context><!--Reserve dagsvaerdi valuta forrige ultimo--><context id="c1677"><entity><identifier scheme="http://www.dcca.dk/cvr">35671099</identifier></entity><period><instant>2021-09-30</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ReserveForCurrentValueAdjustmentsOfCurrencyGainsMember</xbrldi:explicitMember></scenario></context><!--DKK enere--><unit id="u5"><measure>iso4217:DKK</measure></unit><!--Antal--><unit id="u7"><measure>xbrli:pure</measure></unit></xbrl>
